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IDENTIFYING NEW SIGNALING PATHWAYS INVOLVED IN ENGULFMENT  
 
BY FOLLICLE CELLS IN THE DROSOPHILA OVARY: A KINASE SCREEN 
 
ALICE TENZER CHIRN 
 
ABSTRACT 
 
Programmed cell death and cell corpse clearance are an essential part of an 
organism’s overall health and development. Cell corpses are often engulfed by 
professional phagocytes such as macrophages. However, in certain tissues, 
neighboring non-professional cells can also carry out phagocytic functions. Here, 
we use the Drosophila melanogaster ovary to investigate novel genes required 
for engulfment by non-professional phagocytes. In the Drosophila ovary, 
neighboring epithelial cells facilitate the clearance of dying germline cells. We 
performed an unbiased kinase screen to identify novel proteins and pathways 
involved in cell clearance in the nurse cell. Several genes identified in this screen 
were members of the phosphoinositide 3-kinase (PI3K) family. The class II and III 
PI3Ks are required for nurse cell clearance and acidification during late-stage 
oogenesis. Class I PI3K is required for progression during engulfment in mid-
stage oogenesis. This kinase screen has revealed novel genes for further 
exploration and investigation. 
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CHAPTER ONE Introduction 
1.1 Overview of programmed cell death 
 Programmed cell death (PCD) is a process that occurs frequently 
throughout an organism’s lifetime and plays an important role in tissue 
homeostasis, development, and the organism’s overall health. PCD is involved in 
many functions including the sculpting and deletion of structures, controlling cell 
numbers, and eliminating abnormal or harmful cells. As a cell dies, its cell corpse 
must be efficiently cleared through phagocytosis (also known as engulfment or 
efferocytosis). Dysregulation of PCD or engulfment has been implicated in many 
human diseases including cancer, autoimmune diseases, and neurodegenerative 
diseases (Fuchs and Stellar 2011). 
 There are three main types of PCD: apoptosis, autophagic cell death, and 
necrosis. The various types of cell death are characterized by their morphological 
and biochemical characteristics. While these three types of cell death are the 
most well-defined, other types of cell death have been classified as well 
(Kroemer et al. 2009; Galluzzi et al. 2012) 
 
1.2 Major forms of programmed cell death 
1.2.1 Apoptosis 
 Apoptosis is described as “cell suicide”, and is identified by morphological 
changes and caspase activation. When a cell receives pro-apoptotic signals, it 
goes through a series of changes that includes cell shrinkage, chromatin 
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condensation, nuclear and organelle fragmentation, and membrane blebbing 
(Kroemer et al. 2009). 
 Caspases have been found to be key regulators of apoptosis. Caspases 
are divided into two groups: initiator caspases and executioner caspases. In flies, 
initiator caspases include Death-related ced-3/Nedd2-like caspases (Dredd) and 
Dead regulator Nedd2-like caspase (Dronc). Executioner caspases, in 
Drosophila, include Ice (or Drice) and Death caspase 1 (Dcp-1) (Fuchs and 
Steller 2015). 
 Inhibitor of apoptosis proteins (IAPs) add another layer of apoptosis 
regulation by directly inhibiting caspase activity. IAPs are characterized by their 
BIR (baculovirus inhibitory repeat) domain that directly binds to and inhibits 
caspases. In Drosophila, Diap1 (Death-associated IAP1) regulates caspase 
activation and cell death. 
 The next layer of regulation involved IAP antagonists. These proteins 
contain an IAP binding motif that is required for IAP binding and inactivation. In 
Drosophila, there are three IAP antagonists: Reaper, Grim, and Hid (Head 
involution defective). In the absence of these three genes, embryonic apoptosis 
is completely inhibited. Ectopic expression of these three genes leads to a potent 
induction of apoptosis (Steller 2008; Fuchs and Steller 2015). Figure 1.1 shows a 
simplified schematic of the apoptosis pathway. 
 
1.2.2 Autophagic cell death 
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 Autophagic cell death is defined morphologically by the presence of 
autophagosomes and lysosomes in a dying cell. However, the term “autophagic 
cell death” suggests that autophagy (or “self-eating”) is the cause of death when 
in reality, autophagy contributes to cell death. Autophagy plays a dual role in the 
cell by mediating cell survival and cell death (Maiuri et al. 2007; Ryoo and 
Baehrecke 2010). 
 Autophagy genes (Atg) were first discovered in Saccharomyces 
cerevisiae. These genes have homologous genes in other organisms including 
Drosophila and mice. Autophagy contributes to cell survival under nutrient-
limiting conditions by catabolizing intracellular resources for protein synthesis or 
bioenergetics needs. Autophagy can also be induced to remove damaged 
organelles to eliminate toxic protein aggregates (Lum et al. 2005). 
 Autophagy is also involved in cell death. Loss of Atg genes have been 
shown to promote apoptosis (Boya et al. 2005). Atg genes are also required to 
promote cell death in the presence and absence of caspase activity (Das et al. 
2012). Thus the Nomenclature Committee on Cell Death (NCCD) reintroduced 
autophagic cell death as a type of cell death that can be suppressed by inhibiting 
at least two autophagic genes (Galluzzi et al. 2012). 
 Recent studies have unearthed a new form of non-apoptotic autophagy-
dependent cell death: autosis. Autophagy-inducing peptides are able to induce 
autosis. Cell death was blocked when autophagy was inhibited, but not when 
apoptosis or necrosis were inhibited. Additionally, this autophagy-dependent cell 
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death exhibited morphological characteristics distinct from apoptotic and necrotic 
morphology (Liu and Levine 2015). 
 
1.2.3 Necrosis 
 Necrosis is now recognized as a type of programmed cell death rather 
than an accidental or uncontrolled cell death. Necrosis is morphologically 
characterized by the swelling of the cell and organelles, rupture of the plasma 
membrane and nuclei, and cell lysis. Necrotic cells also show a rise in cytosolic 
Ca2+, reactive oxygen species, and RIPK activation (McCall 2010, Yuan and 
Kroemer 2010, Kroemer 2009) 
 Advancements in understanding programmed necrosis (or necroptosis) 
have led to the discovery of initiators, modulators, and effectors of necroptosis. 
Induction of necroptosis begins with the initiation of TNF (Tumor necrosis factor) 
signaling. TNF binds to the TNFR1 (TNF receptor 1). TNFR1 activation leads to 
the formation of RIPK1 (Receptor-interacting protein kinase 1) and TRADD 
(TNFR1-associated death domain)-dependent receptor-bound complex I 
formation. This complex then activates NF-kB (Nuclear factor-kB) to upregulate 
anti-apoptosis genes. Internalization of complex 1 leads to a change in its binding 
partners that now include TRADD, FADD (FAS-associated protein with a dead 
domain), Caspase 8, RIPK1, and RIPK3. Normally, Caspase 8 will trigger 
apoptosis. However, inhibition of Caspase 8 via genetic or pharmacological 
intervention leads to the phosphorylation of RIPK3. This phosphorylation recruits 
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MLKL (Mixed lineage kinase domain-like), and MLKL phosphorylation by RIPK3 
results in activation of JNK, production of reactive oxygen species (ROS), and 
necroptosis. Necrotic cells are then internalized by phagocytes through the 
formation of macropinosomes (Vandenabeele et al. 2010; Berghe et al. 2014).  
 
1.3 Phagoptosis 
 Aside from the three major types of PCD, there are other forms of cell 
death. Phagoptosis is a type of cell death in which a phagocytic cell directly 
induces the death of a neighboring cell via “murder” or “assisted suicide”. 
Phagocytes were thought to only engulf dead of dying cells initiate by apoptosis 
or necrosis. However, recent studies have shown phagoptosis occurs when a 
neighboring cell displays “eat me” signals, or experiences a loss of “don’t eat me 
signals” on the cell surface. The exposure or loss of these surface signals may 
originate from the phagocyte or from elsewhere in the in the organism. In both 
scenarios, inhibition of phagocytosis prevents cell death (Reviewed in Brown and 
Neher 2012). 
 
1.4 Engulfment 
 The final step in cell death is the clearance of the cell corpse. Cell corpse 
removal is mainly mediated through professional and non-professional 
phagocytes. These phagocytes may be neighboring cells or recruited from 
elsewhere in the organism. If phagocytes need to be recruited, the dying cells will 
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release “find me” signals. Potential “find me” signals have been reported in 
mammals that include lysophosphatidylcholine, fractalkine, nucleotides ATP and 
UTP, and sphingosine 1-phosphate. However the mechanisms behind their 
release from dying cells remain to be elucidated.  
 Dying cells also express “eat me” signals on the cell surface. “Eat me” 
signals may be modified or newly exposed lipids, proteins, or sugars. The most 
well-studied “eat me” signal is the exposure of phosphatidylserine on the outer 
plasma membrane leaflet. Once the phagocyte is in close proximity, engulfment 
receptors on the phagocyte recognize the “eat me” signals on the surface of the 
dying cell. The phagocyte then proceed to engulf the dying cell, and the cell 
corpse is processed and degraded (Lorenz and Ravichandran 2007; Elliot and 
Ravichandran 2010). The steps of engulfment are outlined in Figure 1.2. 
 Draper has been found to be one of the main engulfment receptors in 
Drosophila. Draper (Ced-1 C. elegans homolog) was first shown to be required in 
glia for engulfment of apoptotic neurons in the fly embryonic central nervous 
system. Draper mutants were found to have un-engulfed cell corpses (Freeman 
et al. 2003). Draper is also required for engulfment in other contexts including 
axonal injury, hemocytes, and the ovary (Manaka et al. 2004; MacDonald et al. 
2006; Etchegaray et al. 2012).  
 
1.5 JNK signaling and engulfment 
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 The Jun-N-terminal kinase pathway (JNK) is an evolutionarily conserved 
signaling pathway that follows the MAPKKK/MAPKK/MAPK hierarchy of Mitogen 
activated protein kinase (MAPK) signaling pathways. MAPK signaling pathways 
rely on a three-tier signaling cascade of sequential phosphorylations. The MAPK 
kinase kinase (MAPKKK) is a Ser/Thr kinase that phosphorylates and activates 
MAPKK (MAPK kinase). Once activated, MAPKK phosphorylates its target 
MAPK. MAPK then phosphorylates its substrate(s) (transcription factors, 
cytoskeleton associated proteins, and other kinases). This signaling pathway can 
lead to many different outputs and cellular processes including differentiation, 
proliferation, apoptosis, and stress response (Rios-Baeera and Riesgo-Escovar 
2012). 
 In Drosophila, the JNK pathway is one of the three evolutionarily 
conserved MAPK pathways that regulates cell death. In Drosophila, there is only 
one JNK protein (Basket or Bsk). Bsk is activated by one of the two JNKKs. 
JNKK can be activated by multiple JNKKKs, and JNKKK activation can be 
activated by many different intracellular proteins. Each JNK signaling module can 
be activated by extracellular ligand/receptor combinations. Activation of JNK 
leads to the phosphorylation of Jun (Jun-related antigen) and Kayak transcription 
factors. Puckered (Puc) is a phosphatase that works as a negative regulator of 
JNK signaling (Geuking et al. 2009; Igaki 2009) (Figure 1.3). 
 Recent studies have shown that the JNK pathway is required for 
engulfment in many different tissues. JNK signaling is required for the engulfment 
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of neighboring epithelial cells in the imaginal discs (Ohsawa et al. 2011). JNK is 
also required in glia for the removal of severed axons in Drosophila brain 
(MacDonald et al. 2013). In the fly ovary, JNK signaling and its upstream 
engulfment receptor, Draper, are activated and required for follicle cell 
engulfment of germline material following cell death (Etchegaray et al. 2012).  
 
1.6 Drosophila ovary as a model system for programmed cell death and 
engulfment 
 The Drosophila female has two ovaries, and each ovary consists of 15-20 
ovarioles. Ovarioles are strings of progressively developing egg chambers that 
continuously produce egg chambers. The anterior end of the ovariole houses the 
germarium that contains germline and somatic stem cells. As the egg chambers 
develop, they go through 14 stages of oogenesis before they are laid through the 
oviduct at the posterior end of the ovary. Each egg chamber consists of an 
oocyte and 15 germline-derived nurse cells (NC). The germline is surrounded by 
a layer of somatically-derived epithelial cells called follicle cells (FC) (Figure 1.4). 
Nurse cells are specialized polyploid cells that produce mRNAs, proteins, and 
organelles to support the oocyte throughout oogenesis (King 1970; Spradling 
1993).  
 Cell death primarily occurs at three points during fly oogenesis. Cell death 
can be induced through nutrient deprivation within the germarium and during the 
mid-stages of oogenesis (stages 7-9). These mid-stage dying egg chambers will 
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progress through the “phases of death”. Cell death also occurs in late oogenesis 
as a natural part of egg chamber development. As the egg chamber progresses 
from stage 10 through stage 14, the nurse cells must die and be cleared (Figure 
1.4). 
 In addition to nurse cell elimination, somatic follicle cells can also die 
throughout oogenesis. As mid-stage dying egg chambers progress through the 
phases of death, follicle cells engulf the germline material. As the egg chamber 
approaches the end of engulfment, follicle cells begin to lose membrane markers, 
become pyknotic, and eventually disappear. During late-stage oogenesis, some 
FCs also begin to die as they fulfill their support functions. At the end of 
oogenesis, follicle cells detach from the mature egg chamber as it passes 
through the oviduct. These remaining follicle cells accumulate at the oviduct and 
are engulfed (Pritchett et al. 2009; Jenkins et al. 2013).  
 
1.6.1 Starvation-induced cell death during mid-stage oogenesis 
 In well-fed flies, cell death occurs sporadically during mid-stage 
oogenesis. However, cell death can be induced at this point through 
nutrient/protein starvation. Starvation-induced cell death during mid-oogenesis is 
characterized by nurse cell condensation and fragmentation, and follicle cell 
engulfment. Mid-stage degenerating egg chambers proceed through “phases” of 
death” (Figure 1.5). 
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 In most Drosophila tissues, cell death is regulated by the IAP binding 
proteins Reaper, Hid, and Grim. Interestingly, cell death during mid-oogenesis is 
not regulated by these proteins. When these genes are simultaneously mutated 
in nutrient-deprived flies, mid-stage dying egg chambers resemble wild-type 
dying egg chambers. Mutations in other cell death regulators also do not affect 
mid-stage starvation-induced cell death. These data imply a novel pathway is 
responsible for PCD in the Drosophila ovary (Peterson et al. 2007; Pritchett et al. 
2009).  
 Caspases play an important role in executing apoptosis. Effector caspase 
Dcp-1 is required for mid-stage PCD in nutrient-deprived flies. Dcp-1 null flies 
exhibit an “undead” or “PWOP” (peas without a pod) phenotype of uncondensed 
nurse cell nuclei without any surrounding follicle cells. Additionally, 
overexpression of caspase inhibitors Diap1 and p35 produce an undead 
phenotype. Interestingly, initiator caspase single mutants (Strica and Dronc) do 
not affect mid-stage PCD. However, double Strica; Dronc mutants exhibit a 
moderate undead phenotype, suggesting a redundant role for these two 
caspases (Baum et al. 2007; Pritchett et al. 2009).  
 Autophagy also contributes to starvation-induced mid-stage PCD. 
Degenerating egg chambers have an increased accumulation of 
autophagosomes/autolysosomes and acidic vesicles. Flies with mutations in 
autophagy genes Atg 7 and Atg 1 were shown to be involved in nurse cell 
chromatin fragmentation. Autophagy is also affected by caspase activation 
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(reviewed in Pritchett et al. 2009; Jenkins et al. 2013). All of these data suggest a 
novel cell death pathway that involves autophagy and caspase-dependent 
apoptosis to promote PCD during mid-stage oogenesis. 
 Engulfment by follicle cells during starvation-induced mid-stage oogenesis 
requires the engulfment receptor Draper. Engulfment genes Rac1 and Shark are 
also required for follicle cell engulfment. When these genes are mutated or 
knocked out, follicle cells fail to enlarge or engulf, leading to persisting dead egg 
chambers. Engulfment-defective egg chambers exhibit lingering germline 
material and premature follicle cell death. Draper lies upstream of JNK signaling, 
and activation of JNK signaling is required for follicle cell engulfment. Constitutive 
activation of Hemipterous (Hep), a JNK kinase, is sufficient to induce follicle cell 
engulfment in the absence of Draper. Furthermore, over-expression of 
constitutively active Hep in a wild-type background is enough to induce 
engulfment and nurse cell death in the absence of starvation. These data 
suggest that JNK activation, through other pathways, can promote engulfment in 
the absence of Draper (Etchegaray et al. 2012; Jenkins et al. 2013).  
 While JNK signaling is involved in engulfment in the fly ovary, the 
mechanisms behind its activation are still unknown. Caspases are not necessary 
to activate JNK or Draper activity in follicle cells. Thus a caspase-independent 
pathway may be required for engulfment. Signaling between the germline and 
follicle cells occur for the mutual coordination of cell death. The interactions 
between the germline and follicle cells remain to be elucidated.  
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1.6.2 Developmental cell death in late-stage oogenesis 
 As egg chambers progress toward the later stages of oogenesis, nurse 
cells (NC) must transfer their cytoplasmic contents to the oocyte through ring 
canals in a process called dumping. After dumping, the NC nuclei are removed. 
By stage 14 of oogenesis (characterized by fully formed dorsal appendages), 
nurse cell material has been completely eliminated (Figure 1.6). Many 
engulfment mutants exhibit persisting nurse cell nuclei at stage 14, and may 
disrupt the dumping process. However, it is unclear whether dumping affects 
nurse cell death, or if the two processes happen to occur concurrently (Jenkins et 
al. 2013). 
 Analysis of nurse cells in stage 12 and 13 suggest a role for apoptosis and 
autophagy in developmental cell death. However, like mid-stage starvation-
induced cell death, developmental cell death does not require reaper, grim, or 
hid. Mutations in caspases or overexpression of caspase inhibitors only result in 
partial nurse cell death defects. Mutants defective in autophagy also result in mild 
cell death defects. Additionally, mutants defective in apoptosis and autophagy do 
not show severe persisting nuclei phenotypes (Foley and Cooley 1998; Peterson 
and McCall 2013; Jenkins et al. 2013).  
 More recently, follicle cells have been implicated in promoting 
developmental cell death. Stretch follicle cells (a subset of follicle cells) begin to 
appear in the anterior end of stage 9 egg chambers, when the majority of follicle 
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cells migrate to the oocyte. In stage 11, the stretch follicle cells begin to project 
extensions between the nurse cells. By stage 12, dumping is complete and the 
stretch follicle cells completely surround the nurse cell nuclei. Stretch follicle cells 
continue to remain associated with nurse cell nuclei until all of the nuclei are 
eliminated. Stretch follicle cells and Draper are required for proper nurse cell 
clearance (Timmons et al. 2016). 
 In C. elegans, ced-1 (Draper ortholog) acts in parallel to ced-12, another 
engulfment gene (Reddien and Horvitz 2004). A candidate screen revealed that 
follicle cell specific knockdown of ced-12 in Drosophila results in a persisting 
nuclei (PN) phenotype. In fact, Draper; ced-12 double mutants have a more 
severe persisting nuclei phenotype compared to single mutant knockdowns. 
Draper and ced-12 are also required in follicle cells for the acidification of nurse 
cells (visualized as LysoTracker positive puncta and nurse cells) (Timmons et al. 
2016). 
 JNK signaling is also required in follicle cells for nurse cell clearance. 
Knockdown of JNK signaling members leads to persisting nuclei phenotypes. 
JNK signaling is required to sustain Draper levels on the follicle cell membrane. 
ced-12 is required throughout late-stage oogenesis for Draper enrichment on 
follicle cell membranes and to activate JNK (Timmons et al. 2016). Thus, many of 
the same components of the engulfment machinery are required in both mid and 
late oogenesis for nurse cell clearance.  
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1.7 Kinases overview 
 Kinases are important regulatory enzymes that phosphorylate a variety of 
molecules. The reversible activation of the kinase pathways can lead to many 
biological processes, including cell proliferation, survival, migration, and death. 
Regulation of kinase signaling is implicated in many diseases, including cancer 
and neurodegeneration (Johnson and Nakamura 2007; Fleuren et al. 2016). 
Thus, there has been increased interest in understanding kinases and their 
regulatory networks as a target for therapeutic drugs. 
 In Drosophila, many of the kinases phosphorylate proteins. These 
enzymes belong to a protein superfamily that has a common catalytic structure. 
The kinases can be further divided into sub-groups based on structure and 
function. These groups include AGC, atypical, CaMK (Ca2+/calmodulin-depend 
kinase), CK1 (casein kinase 1), CMGC, Ste, TK (tyrosine kinase), TKL (tyrosine 
kinase-like), RGC (receptor guanylate cyclase), and other. Drosophila also have 
lipid kinases. Many of these Drosophila kinases are also conserved between C. 
elegans, yeast and mammals. This cross-species homology allows for 
identification of novel genes in known pathways or predictions of protein 
interactions in conserved pathways (Morrison et al. 2000; Manning et al. 2002).  
 Previous work shows that the engulfment receptor Draper works through 
the Jun-N-Terminal kinase signaling pathways to promote engulfment in 
Drosophila follicle cells during mid-oogenesis (Etchegaray et al. 2012).  This 
project focuses on a kinase screen for other kinases and signaling pathways that 
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may be involved in regulating cell death and engulfment in the Drosophila ovary. 
Drosophila have many advantages for genetic analysis. Flies have fast 
generation times, only four chromosomes, and many genetic tools that allow for a 
wide range of genetic manipulations (St Johnston et al. 2002). In this project, we 
used the GAL4/UAS system to specifically knockdown each kinase in follicle cells 
for targeted gene expression. We identified a number of kinases require for 
engulfment, and for this thesis, I decided to further investigate several genes 
identified in this screen that are members of the phosphoinositide 3-kinase 
(PI3K) family.  
 PI3Ks phosphorylate the hydroxyl group of position 3 on the inositol ring of 
phosphoinositides to induce different signals. PI3Ks are implicated in regulating 
proliferation, survival, metabolism, cytoskeletal rearrangements, and membrane 
trafficking. There are three classes of PI3Ks, each with their own structure and 
function. Figure 1.7 illustrates the different classes of PI3Ks and their substrates. 
(Vanhaesebroeck 1997; Leevers 1999; Thorpe et al. 2015). 
 
1.7.1 Class I PI3K 
 Class I PI3Ks are categorized by their structure and function. Class I 
PI3Ks consist of a heterodimer with a catalytic and adaptor subunit. While they 
can phosphorylate PtdIns (Phosphatidylinositol), PtdIns4P, and PtdIns(4, 5)P2, 
their preferred substrate in vivo is PtdIns(4, 5)P2. PI3K is activated through 
extracellular signaling and receptors on the cell surface. PI3K is recruited to the 
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receptors at the plasma membrane and positioned in close proximity to its lipid 
substrates. Once phosphorylated, the lipid products interact with other proteins 
through specific lipid binding domains to modulate activity and/or localization. 
Class I PI3Ks are largely inactive in quiescent cells (Vanhaesebroeck 1997; 
Wymman and Pirola 1998; Vanhaesebroeck et al. 2010).  
 Class I PI3Ks are further divided into A and B subclasses according to the 
adaptor subunit. The PI3KA subunit contains Src homology 2 (SH2) domains that 
bind phosphorylated tyrosine residues (Vanhaesebroeck 1997). Class IA 
enzymes are generally activated by receptor tyrosine kinases and G-protein-
coupled receptors (GPCRs) either directly by G-proteins or indirectly through 
small oncogenes. Class IB subunits do not contain the SH2 domain. Instead they 
interact with trimeric G-proteins. Class 1B enzymes are general activated through 
GPCRs (Vanhaesebroeck 2010). 
 Perhaps the most well studied PI3KA signaling pathway is the 
Insulin/PI3K/Atk pathway (Figure 1.8). This pathway is highly conserved between 
C. elegans, Drosophila and mammals, and is important in nutrient sensing. In 
flies, Insulin-like peptides (Ilps) bind to the insulin receptor and convert 
PtdIns(4,5)P2 (PIP2) to PtdIns(3,4,5)P3 (PIP3) either through PI3-kinase directly 
or through Chico, an insulin receptor substrate. Once PIP3 is produced on the 
cytoplasmic side of the plasma membrane, Akt (also known as Protein kinase B), 
interacts with PIP3 through its PH domain (Pleckstrin homology domain). This 
interaction causes a conformational change in Akt that exposes Thr308 and 
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Ser473. The PH domain also aids in the heterodimerization of Akt and Pdk1. 
Pdk1 is then recruited to these amino acid sites and phosphorylates Thr308. 
Akt/Pdk1 activation then causes downstream activation in cell proliferation and 
cell survival through various downstream proteins. PTEN works as a negative 
regulator of this pathway by converting PIP3 back to PIP2 (Osaki 2004; 
Taniguchi et al 2006; Giannakou and Partidge 2007).  
 Akt can go on to activate TOR signaling. TOR consists of two complexes, 
TOR complex 1 (TORC1) and TOR complex 2 (TORC2). Akt activates TORC1 
by phosphorylating Tsc2 (Tuberous sclerosis complex protein 2) and PRAS40 (a 
TORC1 inhibitor). Unphosphorylated Tsc2 complexes with Tsc1 and Melted to 
inhibit Rheb GTPase activity. GTP bound Rheb activates TORC1. Thus Akt 
phosphorylation of Tsc2 reverses Tsc2 inhibition of Rheb, and Rheb is free to 
activate TORC1. PRAS40 binds TOR to inhibit its activity. Upon phosphorylation 
by Akt, PRAS40 dissociated from TOR. TORC1 then activates S6 kinase (S6K) 
and represses 4E-BP (a transcriptional regulator) to regulate protein synthesis 
and cellular growth. Akt can also target FOXO (Forkhead box transcription factor) 
to mediate growth and stress responses. Cells can also respond to nutrient 
availability through TOR signaling independent of insulin receptors. Slimfast is an 
amino acid transporter that regulates TOR activity through Rag GTPases (Evans 
et al. 2011; Shim et al. 2013).  
 Insulin signaling has been implicated to be involved in programmed cell 
death. In the Drosophila ovary, proper nutrition is vitally important for egg 
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chamber development. Nutrient deprivation can induce PCD in the germarium 
and during mid-oogenesis (Buszczak and Cooley 2000).  Recent studies have 
begun to investigate the role of insulin signaling in mid-stage PCD. Germline 
clones (GLCs) of multiple insulin signaling components (Insulin receptor, Chico, 
Tor, S6K) do not mimic starvation-induced cell death (Pritchett and McCall 2012). 
Instead, these mutants exhibit PWOP (peas without a pod) phenotypes or mixed 
phenotypes with PWOPs and normal degenerating egg chambers under starved 
and well-fed conditions. PWOP egg chambers were not able to induce caspase 
activity or lysosome formation, and showed moderate levels of Diap1. Tor 
mutants resemble wild-type starvation induced egg chambers with decreased 
levels of Diap1. Interestingly, PI3K activity is present in wild-type flies, but 
depleted in insulin mutants. These results suggest an alternative pathway that 
may regulate the TOR pathway to induce PCD. 
 Interestingly, follicle cells signal nutrient availability to the germline through 
systemic Ilp secretions from the brain. Egg chambers cultured from starved flies 
are able to reverse their starvation response when supplemented with 
exogenous insulin (Shimada et al. 2011). Rapamycin can be used to inhibit 
insulin signaling. Rapamycin is a drug that binds to TOR to inhibit its function 
(Ballou and Lin 2008). In egg chambers cultured from well-fed flies, the addition 
of rapamycin causes the egg chambers to mount a starvation response similar to 
starved egg chambers (Burn et al 2015). Decreased Drosophila Ilp expression 
from the insulin producing cells of the brain results in a starvation response 
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despite well-fed conditions. Interestingly, inhibition of insulin/TOR signaling in the 
follicle cells induces a starvation response despite well-fed conditions. 
Furthermore, stimulation of the insulin pathway in follicle cells prevents a 
starvation response. These data suggests a role for follicle cells in transmitting 
nutrient availability and information to induce or prevent a starvation response in 
the germline.  
 
1.7.2 Class II PI3K 
 Mammals have three class II isoforms: PI3K-C2α, PI3K-C2β, and PI3K-
C2γ. Drosophila and C. elegans both possess only one class II isoform. Class II 
PI3Ks contain a Ras-binding domain, a C-terminus extension with a PX (Phox 
homology) domain, and another C2 domain. The N terminus extensions are 
different for each mammalian isoform. Unlike class I PI3Ks, they do not have a 
regulatory domain. In vitro and in vivo studies have shown these kinases to 
primarily phosphorylate PtdIns (Falasca and Maffucci 2007; Jean and Kiger 
2014) 
 Class II PI3K function was recently implicated to be required in the cell 
cortex. However, most class II PI3K functions have been attributed to activation 
of their substrate (PtdIns3P). PtdIns3P activity is involved in cell signaling and 
intracellular membrane trafficking. Pools of PtdIns3P are generated in response 
to cellular stimulations and may act as an intracellular messenger. Some of these 
stimuli involved in class II PI3K activation include chemokines, cytokines, and 
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LPA. Insulin, epidermal growth factor and platelet-derived growth factor receptors 
are also implicated to interact with class II PI3Ks (Falasca and Maffucci 2007; 
Jean and Kiger 2014).  
 In C. elegans, regulation of PtdIns3P pools are implicated in apoptosis 
and cell clearance. Generation of PtdIsn3P pools on phagosomal membranes is 
required for phagosome maturation and corpse processing. In C. elegans, 
apoptotic cell corpses are engulfed by phagosomes and degraded via the CED-1 
engulfment receptor. CED-1 activation also leads to production of PtdIns3P pools 
on phagosome membranes. PIKI-1, the C. elegans class II PI3K, produces 
PtdIns3P pools on phagosomes, and the generation of these pools is required for 
cell corpse degradation. VPS-34, the C. elegans class III PI3K also produces 
PtdIns3P on phagosome membranes upon activation. These two PI3Ks act 
sequentially to generate PtdIns pools to regulate phagosome maturation and 
corpse degradation, but not engulfment (Lu et al. 2012). 
 The lipids on the phagosome membrane can act as signaling molecules or 
localization cues for other proteins involved in phagosome maturation and corpse 
processing. Recent studies in the Drosophila ovary reveal that the engulfment 
receptor, Draper, is present on nascent, PtdIns3P positive phagosomes during 
starvation-induced mid-stage PCD (Meehan et al. 2016). The presences of these 
PtdIsn3Ps may act to recruit proteins necessary for proper phagosome 
maturation. Analysis of engulfment and corpse processing genes in follicle cells 
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suggest cross-talk between engulfment and corpse processing machinery for 
complete engulfment and degradation of corpse material.  
 
1.7.3 Class III PI3K 
 Class III PI3-kinases were first identified in Saccharomyces cerevisiae. 
Also known as Vps34 (Vacuolar protein sorting 34), this kinase is the only PI3K 
in yeast. Vps34 homologs have been identified in many other organisms 
including C. elegans, Drosophila, and mammals. Vsp34 complexes with Vps15, 
and several other proteins, to activate downstream effectors such as PtdIns. 
Vsp34 signaling is mediated through recruitment of proteins that can bind to 
PtdIns3P via PX or FYVE (zinc finger) domains. Vps34 functions primarily in 
vesicular trafficking, protein sorting, and autophagy (Backer 2008; 
Vanhaesebroeck et al. 2010; Backer 2016).  
 
1.8 Thesis rationale 
 Programmed cell death plays an important role in tissue homeostasis, 
development, and maintaining an organism’s overall health. PCD also ensures 
that excess or damaged cells are cleared without any damage to the organism 
(Fuchs and Steller 2011). Professional phagocytes often perform these 
engulfment roles. However, non-professional phagocytes, such as neighboring 
epithelial cells, can also transition to these engulfment roles. The mechanisms 
and pathways involved in non-professional phagocytosis remain to be elucidated. 
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 The Drosophila ovary provides an excellent model to study PCD due to 
the cell death events that occur during mid and late-oogenesis. During mid-stage 
oogenesis PCD can be induced through nutrient starvation. As egg chambers 
begin to degenerate, neighboring epithelial follicle cells are responsible for the 
clearance of germline-derived nurse cells. During late-oogenesis, nurse cell 
nuclei must be cleared as a normal part of development. Thus, death can be 
induced in vivo as a model for cell death and engulfment. Cell death can also be 
observed in every ovary as a natural progression of oogenesis. Drosophila also 
have a wide range of genetic tools that allow for easy manipulation to study 
programmed cell death and cell clearance 
 Kinases are important regulatory enzymes that are involved in a variety of 
biological processes, including cell survival and cell death. Dysregulation of 
kinases have been implicated in many diseases. Thus kinases provide a starting 
point to identify and understand the complicated regulatory networks in the cell. 
 This project serves to identify novel signaling molecules and pathways 
that may play a role in cell death or nurse cell elimination/engulfment. Several 
genes identified in this kinase screen were part of the PI3-kinase family. Here, 
the role of these kinases in relation to PCD and cell clearance are further 
investigated. 
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Figure 1.1 Core Drosophila apoptotic machinery.  
 
Pro-apoptotic death signal activates inhibitor of apoptosis (IAP) antagonists 
Hid/Reaper/Grim. IAP antagonists mediate the degradation of Diap1, allowing for 
Dcp1 activation. Diap1 inhibition also allows for activation of initiator caspases 
like Dronc. Caspases then lead to apoptosis. Modified from (Fuchs and Steller 
2015).  
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Figure 1.2 Initiation of engulfment by phagocytic cells 
 
 
First the dying cell releases “find me” signals. Once the phagocyte is in close 
proximity, the dying cell exposes “eat me” signals on the cell surface. The “eat 
me” signals then bind to engulfment receptors on the phagocytic cell membrane. 
The cell corpse is then phagocytosed and degraded. Modified from (Elliot and 
Ravichandran 2010).  
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Figure 1.3 JNK signaling pathway 
 
In Drosophila, the JNKKK is activated and phosphorylates JNKK. The JNKK then 
phosphorylates Bsk (JNK). Bsk then phosphorylates and activates transcription 
factors Jun and Fos (Kayak). Puckered (Puc) acts as a negative regulator of Bsk. 
Modified from (Igaki 2009).  
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Figure 1.4 Drosophila anatomy 
  
(A) Female containing two ovaries. The ovaries consist of 15-20 strings of 
progressively developing egg chamber chambers (ovarioles). (B) A single 
ovariole made up of individual developing egg chambers. Each egg chamber is 
comprised of 16 germline derived nurse cells. As the egg chamber matures, one 
of the nurse cells develops into the oocyte. Each egg chamber is also 
surrounded by a layer of somatically derived follicle cells. As the egg chambers 
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progress through the stages of oogenesis, the nurse cells must dump their 
cytoplasmic contents and be cleared (Stages 10-14). The end of oogenesis at 
stage 14 is characterized by no remaining nurse cell nuclei and fully formed 
dorsal appendages.  
(A) Adapted from (Obbard 2010); (Miles et al. 2011);(B) Alla Yalonetskaya.  
  
Figure 1.5 Phases of death during mid-stage oogenesis 
  
Egg chambers from starved flies were stained with DAPI (blue) to label DNA, and α-Dlg (purple) to label cell 
membranes. A germline specific GFP gene trap (G89) was used to label the germline in green. (A) Phase 0: “fluffy” 
dispersed nurse cell nuclei surrounded by an organized layer of follicle cells. (B) Phase 1: beginning of chromatin 
condensation. FC membrane still thin. (C) Phase 2: chromatin condensation with apparent individual nuclear 
regions. Follicle cell membrane enlarges to about double its height. (D) Phase 3: continued chromatin 
 condensation. FC membrane enlarges to about triple its height, and germline material is engulfed. (E) Phase 4: 
chromatin fragmentation and continued follicle cell engulfment. (F) Phase 5: few NC nuclei remain. Most of the 
germline has been engulfed. Adapted from (Etchegaray et al. 2012).   
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Figure 1.6 Developmental cell death progression 
 
Egg chambers from well-fed flies were stained with DAPI to label DNA (blue) and 
α-Dlg (red) to label cell membranes. (A) Stage 11: several NCs that still contain 
cytoplasm. (B) Stage 12: all of the NCs have dumped their cytoplasmic contents 
into the oocyte. NC nuclei persist. (C) Stage 13: dorsal appendages have begun 
to form. Some NC nuclei persist. (D). Stage 14: marked by fully formed dorsal 
appendages and no persisting NC nuclei. Adapted from (Jenkins et al. 2013). 
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Class IA and 1B PI3-kinases have a catalytic and regulatory subunit. Their 
preferred in vivo substrate is PtdIns(4,5) P2. Class II PI3Ks do not have a 
regulatory subunit. Their preferred in vivo substrate is PtdIns. Class III PI3Ks 
have a catalytic and regulatory subunit. Their preferred in vivo substrate is 
PtdIns. Adapted from (Thorpe et al. 2015).  
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Figure 1.8 Insulin receptor/PI3K/Akt pathway in Drosophila 
 
Insulin-like peptides (Ilps in Drosophila) are recognized by the insulin receptor 
(InR) on the plasma membrane. InR then recruits Chico and class I PI3K to the 
plasma membrane. PI3K activation converts PIP2 to PIP3. PIP3 then interacts 
with Pdk1 and Akt. PTEN reverts PIP3 back to PIP2. Akt then activates TOR 
signaling by phosphorylating Tsc2. Rheb is then free to activate TOR complex 1. 
TORC1 goes on to regulate cellular growth. Slimfast receptor acts as an InR-
independent regulator of TOR activity via Rag GTPases. (Adapted from Shim et 
al. 2013).  
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CHAPTER TWO Materials and Methods 
2.1 Drosophila stocks 
 Fly lines were obtained from Bloomington Stock Center, unless indicated. 
Flies were raised at 25°C on standard molasses/cornmeal food. To obtain well 
developed ovaries, flies <20 days old were conditioned on fresh yeast paste for 
48-72 hours, changing fresh yeast paste every 24 hours. To mimic starvation 
induced cell death for mid-stage analysis, flies <20 days old were conditioned on 
fresh yeast paste for 24-48 hours, and then starved on apple juice agar for 16-20 
hours.  
 
2.2 The GAL4/UAS system 
 The GAL4/UAS system is a binary system that allows for targeted gene 
expression in a specific tissue or cell type (Figure 2.1). In one fly, GAL4, a yeast 
transcription factor, is downstream of a genomic enhancer that allows for tissue 
specific expression of GAL4. In another fly, the target gene is cloned downstream 
of the upstream activating sequence (UAS). When these two flies are crossed, 
the progeny contain both elements. GAL4 is expressed and binds to the UAS 
site, thus resulting in tissue specific expression of the target gene (Brand and 
Perrimon 1993). 
 For the kinase screen, GR1-GAL4 G89 virgin females were crossed with 
males containing UAS-RNAi lines to knockdown kinase genes specifically in the 
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follicle cells. The GR1-GAL4 flies contained G89 (G00089), a GFP gene trap that 
express endogenous GFP in the germline (Morin et al. 2001).  
 
2.3 Fly dissection 
 Flies were first anesthetized with CO2 gas. Females were sorted from 
males. Using a pair of forceps, the female was grasped in the thorax and 
submerged in Grace’s Insect Medium (Lonza). A second pair of forceps was 
used to remove the very tip of the abdomen. The ovaries were removed and 
placed in a new glass well with fresh Grace’s medium. The carcass was removed 
and disposed of. After all of the females were dissected, the ovary tissue and 
Grace’s medium was transferred into a 1.5ml Eppendorf tube using a Pasteur 
glass pipette. All of the tissue was collected in the narrow portion of the glass 
pipette to prevent tissue loss. Tissue was fixed within 30 minutes.  
 
2.4 DAPI staining 
 DAPI (4’,6-diamidino-2-phenylindole) is a fluorescent stain that binds to 
DNA. In the fly ovary, DAPI staining allows for visualization of cell nuclei and 
chromatin. In our system, DAPI staining was used to visualize persisting nurse 
cell nuclei in stage 14 egg chambers. In mid-stage oogenesis, DAPI was used to 
visualize progression of death and nurse cell clearance in degenerating egg 
chambers. It was also used to detect prematurely dying or pyknotic follicle cells.  
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 Ovaries were first dissected in Grace’s Insect Medium as described 
above. The Grace’s medium was removed from each Eppendorf tube with a 
plastic fine-tipped pipette. The tissue was fixed in 300ul of Grace’s medium, 
200ul Heptane, and 100ul of 16% paraformaldehyde (Electron Microscopy 
Sciences). The paraformaldehyde was less than a week old. The tubes were 
rotated for 20 minutes at room temperature (RT). After 20 minutes, the fix was 
removed with a fine-tipped plastic pipette. The tissue was rinsed twice with 0.1% 
PBT (1X Phosphate buffered saline (PBS) with 0.1% Triton X-100). The tissue 
was then washed 3X for 20 minutes with PBT while rotating at RT for a total 
wash time of an hour. After the final wash, the samples were rinsed with 1X PBS. 
The PBS was removed and 1-2 drops of Vectashield + DAPI (Vector 
Laboratories) was added to each Eppendorf tube. The samples were then placed 
at 4°C overnight. 
 To mount the tissue, ovary tissue with DAPI was carefully transferred onto 
a glass slide with a glass Pasteur pipette. The tissue was gently teased apart 
with needles and spread evenly on the slide. A coverslip was placed on the slide 
and sealed with nail polish. Slides were stored at 4°C.  
 
2.5 Antibody staining 
 Ovaries were dissected in Grace’s Insect Medium as described above. 
The Grace’s Medium was removed with a plastic fine-tipped pipette. Tissue was 
then fixed while rotating for 20 minutes at room temperature (RT) in Grace’s fix 
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(300ul Grace’s medium, 200ul heptane, 100ul 16% paraformaldehyde <a week 
old ). The fix was removed from each tube and each sample was quickly rinsed 
twice with 0.1% PBT (1X PBS (Phosphate Buffer Saline) with 0.1% Triton X-100). 
Each sample was then washed with fresh 0.1% PBT three times while rotating at 
RT (for a total wash time of 60 minutes). Samples were then blocked at RT for an 
hour on the rotator in PBANG (1X PBS + 0.5% Bovine serum albumin (BSA; 
Fisher) + 5% Normal goat serum (NGS; Life Technologies)). Samples were then 
incubated in PBANG and diluted primary antibody overnight at 4°C.  
 The next morning, PBANG + primary antibody was removed and the 
samples were rinsed 2x with PBT. Samples were then washed 4x for 30 minutes 
with PBT + 0.5% BSA at room temperature (total wash time 2 hours). PBT + 
0.5% BSA was removed and each sample was incubated with diluted secondary 
antibody in PBANG (>300ul) for an hour in the dark on the rotator. The samples 
were protected from light from this point forward. After an hour, the secondary 
antibody/PBANG solution was removed and the samples were rinsed twice with 
0.1% PBT. Samples were then washed with PBT + 0.5% BSA for 2 hours, 
changing washes at least 4 times. The tissue was then rinsed once with 1X PBS. 
1-2 drops of Vectashield + DAPI  was added to each tube and stored at 4°C 
overnight.   
 To mount the tissue, ovary tissue with DAPI was carefully transferred onto 
a glass slide with a glass Pasteur pipette. The tissue was gently teased apart 
38 
 
 
with needles and spread evenly on the slide. A coverslip was placed on the slide 
and sealed with nail polish. Slides were stored at 4°C. 
 Primary antibodies were ɑ-Discs Large (Developmental Studies 
Hybridoma Bank (DSHB)) at 1:100 dilutions in PBANG and ɑ-cleaved DCP-1 
(Cell Signaling Technology) at 1:100 in PBANG. Secondary antibodies were 
goat--ɑ-mouse Cy3 (Jackson ImmunoResearch) and rabbit--ɑ-mouse Cy3 
(Jackson ImmunoResearch) at 1:200 dilutions in PBANG. 
 
2.6 LysoTracker staining 
 LysoTracker (Invitrogen) is a fluorescent dye that labels acidic organelles. 
LysoTracker staining allows us to visualize acidified compartments in mid and 
late stage oogenesis.  
 Ovaries were dissected in Grace’s Insect Medium (Lonza). The ovaries 
were gently teased apart with needles in each glass well before transfer with a 
glass Pasteur pipette to an Eppendorf tube. In each tube, the Grace’s Medium 
was removed and freshly diluted LysoTracker Red DND-99 (Invitrogen) solution 
(1:50 dilution in 1X PBS (Phosphate Buffer Saline)) was added. Samples were 
incubated in LysoTracker solution for 6 minutes at room temperature, while 
gently flicking the tubes a few times. Samples were then rinsed once in 1X PBS 
and left to sit in 1X PBS for 2 minutes. Samples were then washed in PBS for at 
least 30 minutes on the rotator with at least two wash changes. Ovaries were 
fixed for 20 minutes in Grace’s fix (300ul Grace’s medium, 200ul heptane, 100ul 
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16% paraformaldehyde <a week old) while rotating at room temperature. Fix was 
removed and samples were washed in 0.1% PBT (1X PBS + 0.1% Triton X-100) 
with three changes of wash for a total wash time of 10-15 minutes. PBT was 
removed and 1-2 drops of Vectashield + DAPI  was added to each tube. Samples 
were incubated in DAPI overnight at 4°C.  
 To mount the tissue, ovary tissue with DAPI was carefully transferred onto 
a glass slide with a glass Pasteur pipette. The tissue was gently teased apart 
with needles and spread evenly on the slide. A coverslip was placed on the slide 
and sealed with nail polish. Slides were stored at 4°C. 
 
2.7 TUNEL staining 
 TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) is 
an assay that detects DNA fragmentation. DNA fragmentation is an important 
step in the breakdown and clearance of nurse cells. In mid-stage oogenesis, 
DAPI stained nurse cell nuclei are visibly fragmented and cleared as starvation 
induced PCD progresses. These wild-type mid-stage dying egg chambers are 
also TUNEL positive. In late-stage oogenesis, apoptosis plays a minor role in 
developmental PCD. However, DNA fragmentation has been observed with 
positive TUNEL staining (Sarkissian et al. 2014). 
 TUNEL staining was done with the DeadEnd Fluorometric TUNEL system 
(Promega). Ovaries were dissected in a solution of 2% PFA + PBS (490 ul 1X 
PBS (Phosphate Buffer Saline) + 70 ul 16% paraformaldehyde (PFA) <a week 
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old). Ovaries were gently teased apart with needles in the glass wells. Ovaries in 
2% PFA + PBS were transferred from the glass wells into 1.5 ml Eppendorf tube 
with a glass Pasteur pipette. The dissecting solution was removed with a plastic 
fine-tipped pipette, and fresh 2% PFA was added to each tube. Ovaries were 
fixed in 2% PFA for a total of 50 minutes while rotating at room temperature. The 
PFA was removed and the samples were rinsed twice with 1% PBT (1X PBS with 
1% Triton X-100). Samples were washed in 1% PBT for over 40 minutes at least 
three times while rotating. On the last wash, the tissue was transferred to a 0.5 
ml Eppendorf tube with a glass Pasteur pipette.  
 Samples were washed for 10 minutes in 20-40 ml of equilibration buffer. 
The tubes were gently tapped to mix, and then placed on a shaker at room 
temperature. The equilibration buffer was removed with a fine-tipped plastic 
pipette. TdT reaction was added to each tube (45 ul Equilibrium buffer, 5 ul 
Nucleotide mix, 1 ul TdT enzyme). The samples were protected from light from 
this point forward. Samples were incubated for 3 hours in 37°C water bath. 
 After 3 hours, 300 ul 2X SCC solution (20X SCC was diluted 1:10 in dH2O) 
was added to each tube for 1 minute. The solution was removed and replaced 
with another 300 ul of 2X SCC solution for 15 minutes. The samples were then 
rinsed three times with 1% PBT. The first two rinses were quick, the last rinse 
was 5 minutes.  
 Samples then underwent antibody staining as follows: 
41 
 
 
Samples were then blocked at room temperature for an hour on the rotator in 
PBANG (1X PBS + 0.5% Bovine serum albumin (BSA; Fisher) + 5% Normal goat 
serum (NGS; Life Technologies)). Samples were then incubated in PBANG and 
diluted primary antibody overnight at 4°C.  
 The next morning, PBANG + primary antibody was removed and the 
samples were rinsed 2x with 0.1% PBT. Samples were then washed 4x for 30 
minutes with PBT + 0.5% BSA at room temperature (total wash time 2 hours). 
PBT + 0.5% BSA was removed and each sample was incubated with diluted 
secondary antibody in PBANG (>300ul) for an hour in the dark on the rotator. 
The samples were protected from light from this point forward. After an hour, the 
secondary antibody/PBANG solution was removed and the samples were rinsed 
twice with 0.1% PBT. Samples were then washed with PBT + 0.5% BSA for 2 
hours, changing washes at least 4 times. The tissue was then rinsed once with 
1X PBS. 1-2 drops of Vectashield + DAPI  was added to each tube and stored at 
4°C overnight.   
 To mount the tissue, ovary tissue with DAPI was carefully transferred onto 
a glass slide with a glass Pasteur pipette. The tissue was gently teased apart 
with needles and spread evenly on the slide. A coverslip was placed on the slide 
and sealed with nail polish. Slides were stored at 4°C. 
 
2.8 Visualization of engulfment during mid-stage oogenesis 
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 To visualize engulfment in mid-oogenesis, egg chambers were stained 
with an antibody against Discs Large (Dlg), a scaffolding protein that labels 
plasma membranes. This staining allowed us to visualize follicle cell membranes 
as they enlarged and engulfed germline material. Additionally, a germline specific 
GFP gene trap (G89) was used to visualize germline material as it was engulfed 
by follicle cells. DNA was stained with DAPI to visualize nurse cell morphological 
changes during death. Wild-type mid-stage death progression is outlined in 
Figure 1.5. 
 
2.9 Visualization of engulfment during late-stage oogenesis 
 DAPI staining was used to label DNA to visualize persisting nurse cell 
nuclei in stage 14 egg chambers. Dorsal appendage formation was used to 
distinguish stage 13 and 14 egg chambers. Stage 13 egg chambers were 
characterized by the beginning of dorsal appendage formation. Stage 14 egg 
chambers were characterized by fully formed, dark dorsal appendages.  Wild-
type late-stage nurse cell clearance is outlined in Figure 1.6. 
 
2.10 Quantification of persisting nurse cell nuclei in late-stage egg chambers 
 Persisting nurse cell nuclei (PN) were quantified in “bins” of 0, 1-3, 4-6, 7-
9, 10-12, 13-15 PN per stage 14 egg chamber. Phenotype severity was 
calculated as the percentage of stage 14 egg chambers with more than 4 PN. 
The average number of PN was calculated using the median number in each bin. 
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GraphPad Prism was used to graph and analyze all PN quantifications. Unpaired 
t-tests were used for all statistical analyses. 
 
2.11 Quantification of acidification of nurse cell nuclei in late-stage egg chambers 
 Stage 13 egg chambers were scored by counting the number of nurse cell 
nuclei. Nurse cell nuclei that were also LysoTracker positive were scored as 
“acidified”. The percentage of acidified nurse cells to un-acidified nurse cells was 
calculated to determine any acidification defects. GraphPad Prism was used to 
graph and analyze all acidification quantifications. Unpaired t-tests were used for 
all statistical analyses. 
 
2.12 Microscopy 
 Samples were viewed with the fluorescence microscope Olympus BX60 
with Olympus Cell Sens Entry microscopy software. The Olympus FluoView 
FV10i microscope was used for all confocal images. All images were analyzed 
and processed in Adobe Illustrator CS6. 
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Figure 2.1 The GAL4/UAS system 
 
 
Follicle cell specific GAL4 driver (GR1-GAL4) virgins were crossed with males 
carrying UAS-kinase RNAi to knock down each kinase in follicle cells. Female 
progeny containing GR1>Kinase RNAi were analyzed for engulfment defects in 
mid and late-stage oogenesis. Adapted from (St Johnston et al. 2002).  
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CHAPTER THREE Kinase screen 
3.1 Kinase screen introduction 
 Kinases have been long identified as important components in cell 
signaling and regulation. Phosphorylation by kinases can lead to many outputs 
such as biological feedback, amplification, and signaling pathways. In turn, 
kinase activity can be regulated by various ligands or phosphorylation 
themselves (Hunter 1987). 
 In Drosophila, the Jun-N terminal kinase (JNK) signaling pathway is 
important for proper nurse cell elimination in the ovary. Draper is an engulfment 
receptor that lies upstream of the JNK pathway. JNK activation in follicle cells is 
required for nurse cell elimination in mid and late stage PCD (Etchegaray et al. 
2012; Timmons et al. 2016). 
 To identify other signaling pathways involved in cell death and clearance 
in the ovary, we performed an unbiased screen using RNA interference (RNAi) to 
knockdown kinase genes only in the follicle cells. Using the GAL4-UAS system, 
we used a follicle cell specific driver (GR1-GAL4) to drive each UAS-kinase-
RNAi. Progeny containing GR1>Kinase-RNAi were conditioned and starved, and 
analyzed for engulfment defects during mid and late-stage oogenesis. 
 Table 3.1 shows an overview of all of the kinase genes that exhibited an 
engulfment defective phenotype. Altogether, 188 unique kinase genes and 281 
RNAi lines were screened out of the 355 kinase genes in the Drosophila kinome 
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(Appendix A.1). 23 genes were found to have strong or very strong engulfment-
defects in mid or late-stage oogenesis. This project was started by Jeffrey Taylor. 
 
3.2 Kinase screen hits for engulfment defects in late-oogenesis 
 As oogenesis progresses to the later stages, nurse cells begin to dump 
their cytoplasmic contents into the oocyte through ring canals. By stage 12, 
dumping is complete, and nurse cells are completely enveloped by stretch follicle 
cells. As the egg chamber progresses through stage 13, the nurse cells are 
cleared. By stage 14, characterized by fully formed dorsal appendages (Das), 
nurse cells are completely eliminated. 
 To analyze developmental cell death phenotypes, GR1>Kinase-RNAi 
females were conditioned for 48-72 hours and dissected. The ovaries were fixed 
and stained with DAPI to visualize DNA. Stage 14 egg chambers were analyzed 
for persisting nurse cell nuclei (PN). PN phenotypic strength was quantified by 
sorting the number of PN per stage 14 egg chambers into bins of 0, 1-3, 4-6, 7-9, 
10-12, 13-15 PN. The percentage of stage 14 egg chambers with more than 4 
PN was calculated to determine phenotype severity. Table 3.2 summarizes the 
kinases required for nurse cell removal in late-stage oogenesis. Genetic 
knockdown of these kinases did not produce an engulfment defect during mid-
stage oogenesis. Table 3.4 summarizes the kinases required in follicle cells for 
engulfment in mid and late-stage oogenesis.  
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 We decided to follow up on a few of kinases that produced a strong or 
very strong PN phenotype. Interestingly, PI3K68D JF01193 and PI3K59F HMS00261 
had severe persisting nuclei phenotypes. These kinases are part of the PI3-kinse 
family. PI3K59F is the Drosophila homolog of the class III PI3K, Vps34. PI3K68D 
is the Drosophila class II PI3K. In C. elegans, the class II and class III (VPS-34 
and PIKI-1) function redundantly in regulating apoptotic cell corpse clearance 
(Zou et al. 2009). While Vps34 has been widely studied for its role in autophagy, 
PI3K68D function in Drosophila is still relatively unknown. Additionally, Vps15 
HMS00908 also showed a strong PN phenotype, and Vps15 complexes with Vps34 
during phagosome maturation (Backer 2008). These results suggest a role for 
class II and class III PI3Ks in nurse cell elimination in late oogenesis. 
 
3.3 Kinase screen hits for engulfment defects in mid-oogenesis 
 To visualize engulfment during mid-stage oogenesis, flies were starved to 
induce programmed cell death. Egg chambers were labeled with an antibody 
against Discs Large (anti-Dlg), a scaffolding protein that labels follicle cell (FC) 
membranes. Starvation-induced cell death progression is characterized through 
morphological changes in nurse cell chromatin, follicle cell membrane 
enlargement, and follicle cell layer integrity. Healthy egg chambers have “fluffy” 
nurse cells (NC) with dispersed chromatin and a thin layer of FC cells. As egg 
chambers progress through the “phases of death”, changes in chromatin and FC 
membranes determine the phase of death.  
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 During phase 1, nurse cell nuclei begin to condense. The follicle cell layer 
is intact, and the FC has not enlarged. During phase 2, the NC nuclei begin to 
fragment and each FC membrane enlarges to about double its original height. 
During phase 3, the NC chromatin continues to fragment further and more 
chromatin disappears. Each FC enlarges further and the cross-sectional area of 
the germline begins to decrease as well. By phase 4, most of the NC nuclear 
fragments have been cleared. The follicle cells continue to enlarge and the 
germline continues to shrink as it is being engulfed. In phase 5, the germline 
region is reduced to a small sliver before the germline material is completely 
engulfed by the FCs. 
 Kinase genes found to be required for PCD only in mid-stage oogenesis 
are listed in Table 3.3. Table 3.4 includes genes that are required for cell death in 
mid and late-stage oogenesis. 
 Interestingly, knockdown of the class I PI3-kinase (PI3K92E) did not 
produce an engulfment-defective phenotype in either mid or late-stage 
oogenesis. However, there appeared to be a delay in follicle cell engulfment 
during starvation-induced cell death. As the egg chambers progressed through 
the phases of death, there was a delay in FC membrane enlargement and 
engulfment between phases 2-4.  
 Additionally, conditioned PI3K92E JF02770 flies showed an interesting 
phenotype with an excessive number of mid-stage dying egg chambers despite 
being conditioned for 48-72 hours. Pdk1 JF02807, a kinase downstream of the 
49 
 
 
PI3K/Akt pathway, exhibited a more severe excessive mid-stage death 
phenotype when conditioned. These results suggest a role for PI3K92E and 
insulin signaling in communicating nutritional availability to induce cell death. 
These data also suggest a role for PI3K92E and its downstream substrates in 
temporally controlling cell death progression.  
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Table 3.1 Summary of genes with phenotypes when knocked down in follicle 
cells 
Kinase genes were knocked down with RNAi specifically in the follicle cells. No 
conclusions are drawn from negative results, as RNAi constructs may be 
ineffective. Starred (*) experiments were performed by Jeffrey Taylor. 
Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC 
Activated 
Cdc42 
kinase * 
HMS00892 VALIUM20 71.0% X X 
BDSC 
Activated 
Cdc42 
kinase-like * 
HMS02328 VALIUM20 N/A  X 
BDSC 
Activated 
Cdc42 
kinase-like * 
JF03110 VALIUM10 N/A  X 
BDSC Arginine kinase * HMS02262 
VALIUM
20 100.0% X  
BDSC Arginine kinase * JF02699 
VALIUM
10 N/A X  
BDSC 
atypical 
protein 
kinase C * 
HMS01689 VALIUM20 N/A X  
BDSC 
Autophagy-
specific 
gene 1 * 
JF02273 VALIUM10 N/A X  
BDSC basket * JF01274 VALIUM1 N/A X  
BDSC basket * JF01275 VALIUM1 N/A X X 
BDSC bent * JF01107 VALIUM1 N/A X  
BDSC 
Calcium/cal
modulin-
dependent 
protein 
kinase I * 
JF02268 VALIUM10 N/A X  
BDSC 
Casein 
kinase I 
alpha * 
JF01792 VALIUM10 N/A X  
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC 
Casein 
kinase II 
beta subunit 
* 
JF01195 VALIUM10 N/A X  
BDSC CASK ortholog * HMS00644 
VALIUM
20 100.0% X  
BDSC 
Cdk5 
activator-like 
protein * 
JF02374 VALIUM10 N/A X  
BDSC CG10082 * HMS00598 VALIUM20 N/A X  
BDSC CG10082 * HMS00427 VALIUM20 N/A X  
BDSC CG10177 * JF01965 VALIUM10 N/A X  
BDSC CG2577 * HMS00054 VALIUM20 N/A  X 
BDSC CG3008 * HM04045 VALIUM20 N/A X  
Vienna CG3837 * HMS02444 VALIUM20 N/A X  
BDSC CG7156 HMS01983 VALIUM20   X  
BDSC CG7177 HMJ02087 VALIUM20 31.0%  X 
BDSC Cyclin T * HMS00776 VALIUM20 N/A X X 
BDSC 
Cyclin-
dependent 
kinase 1 * 
HMS01531 VALIUM20 N/A X  
BDSC 
Cyclin-
dependent 
kinase 1 * 
JF03004 VALIUM10 N/A X  
BDSC 
Cyclin-
dependent 
kinase 1 * 
HMS02212 VALIUM20 N/A X X 
BDSC 
Cyclin-
dependent 
kinase 2 * 
HMS01543 VALIUM20 N/A X X 
BDSC 
Cyclin-
dependent 
kinase 2 * 
HMS00174 VALIUM20 N/A X X 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC 
Cyclin-
dependent 
kinase 9 
HMS01391 VALIUM20 N/A X X 
BDSC 
Diacyl 
glycerol 
kinase * 
JF03396 VALIUM10 N/A  X 
BDSC 
Diacyl 
glycerol 
kinase * 
HMS02341 VALIUM1 N/A X X 
BDSC 
Diacyl 
glycerol 
kinase * 
HMS03005 VALIUM20 N/A X  
BDSC discs large 1 * JF01365 
VALIUM
10 N/A X  
BDSC Downstream of raf1 * HMS00710 
VALIUM
20 N/A X X 
BDSC Downstream of raf1 * HMS00145 
VALIUM
20 36.0%  X 
BDSC Downstream of raf1 * JF01697 
VALIUM
1 N/A X X 
BDSC Downstream of raf1 * HMS00037 
VALIUM
20 N/A  X 
BDSC 
Eph 
receptor 
tyrosine 
kinase * 
HMS01986 VALIUM20 69.0% X  
BDSC foraging * JF01449 VALIUM20 N/A X  
Vienna foraging * HM04080 VALIUM1   X X 
BDSC four-jointed * HMS01310 VALIUM20 71.0%  X 
BDSC 
G protein-
coupled 
receptor 
kinase 2 * 
HMS02330 VALIUM20 100.0% X X 
BDSC 
G protein-
coupled 
receptor 
kinase 2 * 
HMS00161 VALIUM20 N/A X X 
BDSC 
Germinal 
centre 
kinase III * 
HM04054 VALIUM1 N/A X  
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC grapes JF02588 VALIUM10    X 
BDSC 
immune 
response 
deficient 1 
HMS00908 VALIUM20 48.0% X X 
BDSC IplI-aurora-like kinase JF03107 
VALIUM
10    X 
BDSC JIL-1 * HMJ02230 VALIUM20 100.0%  X 
BDSC 
kinase 
suppressor 
of ras 
HMS00730 VALIUM20 63.0%  X 
BDSC LIM-kinase1 JF02063 VALIUM 10 N/A X  
BDSC Lk6 JF02993 VALIUM10 N/A  X 
BDSC lkb1 HMS01351 VALIUM20 32.0%  X 
BDSC meiotic 41 * HMS02331 VALIUM20 22.0% X X 
BDSC Mekk1 * HM05075 VALIUM10 N/A X  
BDSC 
MLF1-
adaptor 
molecule 
JF01435 VALIUM1    X 
Vienna nemo * HMJ02229 VALIUM20   X  
BDSC nemo * HMJ02229 VALIUM20 69.0% X  
BDSC PAK-kinase HM05156 VALIUM10 N/A X X 
BDSC 
PDGF- and 
VEGF-
receptor 
related * 
HMS01662 VALIUM20 N/A X  
BDSC pelle HMS04458 VALIUM20 2.0% X X 
BDSC 
Phosphogly
cerate 
kinase 
HMS00030 VALIUM20 N/A  X 
54 
 
 
Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC 
Phosphotidy
linositol 3 
kinase 59F 
HMS00261 VALIUM20 N/A  X 
BDSC 
Phosphotidy
linositol 3 
kinase 68D 
JF01193 VALIUM1 N/A X X 
BDSC Pi3K92E JF02770 VALIUM10 N/A X  
BDSC 
Protein 
kinase at 
92B * 
HMS00464 VALIUM20 6.0% X  
BDSC Rho-kinase JF03225 VALIUM10   X X 
BDSC Rho-kinase HMS01311 VALIUM20 34.0%  X 
BDSC rolled HMS00173 VALIUM20 16.0%  X 
BDSC 
RPS6-p70-
protein 
kinase 
HMS04459 VALIUM20 5.0% X  
BDSC 
SH2 ankyrin 
repeat 
kinase 
HMS04460 VALIUM20 15.0% X X 
BDSC 
SH2 ankyrin 
repeat 
kinase 
JF01794 VALIUM10 N/A X X 
BDSC skittles JF02796 VALIUM10 N/A X X 
BDSC slipper HMS00742 VALIUM20 43.0% X  
BDSC 
SNF4/AMP-
activated 
protein 
kinase 
gamma 
subunit 
JF02060 VALIUM10 N/A X X 
BDSC Ste20-like kinase JF02614 
VALIUM
10 N/A  X 
BDSC Tao * HMS02333 VALIUM20 N/A  X 
BDSC 
TBP-
associated 
factor 1 
HMS00416 VALIUM20 N/A X X 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
Mid-
oogenesis 
Phenotyp
e 
Late-
oogenesis 
Phenotype 
BDSC telomere fusion HMS02790 
VALIUM
20 24.0%  X 
BDSC Tousled-like kinase HM05272 
VALIUM
10 N/A  X 
BDSC tricornered JF02961 VALIUM10 N/A X  
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CHAPTER FOUR Kinase genes required for nurse cell elimination in late-
oogenesis 
4.1 PI3K68D AND PI3K59F are required for nurse cell acidification and clearance 
 PI3K68D is the Drosophila class II phosphoinositide 3-kinase. While class 
II PI3K function has been characterized in humans, their role and function are still 
relatively unknown in Drosophila. GR1>PI3K68D RNAi (PI3K68D JF01193) flies 
produced a strong persisting nuclei (PN) phenotype in stage 14 egg chambers. 
There was an average of 6 persisting nuclei per stage 14 egg chamber. The 
nurse cells (NC) were able to successfully dump their cytoplasmic contents into 
the oocyte. This was evident as there was no cytoplasmic material left 
surrounding the nurse cell nuclei; only the DNA remained (Figure 4.1). 
 As wild-type developmental death progresses, the nurse cell nuclei are 
acidified in stage 12 and 13. PI3K68D JF01193 flies were stained with LysoTracker 
to visualize acidified compartments. Some stage 13 egg chambers with nurse 
cell nuclei were LysoTracker positive, showing that some of the nurse cells were 
being acidified (Figure 4.2). However, the percentage of acidified NC was 
significantly decreased compared to sibling controls and wild-type flies (Figure 
4.2). Nurse cell acidification was quantified by comparing the number of acidified 
nurse cells to the total number of nurse cells per stage 13 egg chamber. 
PI3K68D JF01193 stage 13 egg chambers had 4% acidified nuclei compared to 
58% acidified nuclei in control flies. Additionally, PI3K68D JF01193 stage 14 egg 
chambers with PN had acidified nurse cell nuclei. These egg chambers also 
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showed a decreased amount of acidification. These two findings suggest a role 
for PI3K68D in follicle cells to facilitate nurse cell acidification.  
 PI3K68D JF01193 stage 13 egg chambers had decreased number of TUNEL 
positive nurse cell nuclei compared to wild-type W1118 ovaries (not shown). More 
data and replicates are needed to determine the if the decrease is significant. 
However, the data suggests a role for PI3K68D in nurse cell fragmentation.  
 PI3K59F is the Drosophila class II phosphoinositide 3-kinase, otherwise 
known as Vps34. Vps34 was first found in yeast and known to play a role in 
autophagy. Vps34 also complexes with Vps15 to form a heterodimer (Backer 
2008). GR1>PI3K59F RNAi (PI3K59F HMS00261) also produced a strong persisting 
nuclei phenotype, and dumping occurred normally during stage 12 (Figure 4.1). 
The average number of persisting nuclei was 4 per stage 14 egg chamber.  
 PI3K59F HMS00261 stage 13 nurse cell nuclei also showed a significantly 
decreased percentage of LysoTracker positive nurse cell nuclei, suggesting that 
the acidification process is disrupted or delayed (Figure 4.2). PI3K59F HMS00261 
egg chambers also have decreased TUNEL positive nurse cell nuclei compared 
to wild-type stage 13 egg chambers (not shown).  
 Vps15 is a kinase that complexes with Vps34, and this complex is 
required for autophagy and endocytosis (Backer 2008). Thus it is not surprising 
that Vps15 HMS00908 also produced a strong persisting nuclei phenotype. These 
data suggest that PI3K59F or its substrates may be required in the follicle cells in 
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late-stage oogenesis to regulate nurse cell acidification, chromatin fragmentation, 
and elimination. 
 
4.2 Discussion and future directions 
 Of the three classes of PI3-kinases, class II kinases are the least 
understood PI3K. Recent studies have shown these proteins are directly involved 
in cellular processes in the cell cortex. However, most class II PI3K function is 
attributed to their substrate, PtdIns3P. 
 Previous work shows potential cross talk between engulfment and 
phagocytic maturation proteins in starvation-induced cell death in Drosophila. 
The engulfment receptor Draper and PtdIns3P lipids are both present on nascent 
phagosomes (Meehan et al. 2016). Additional studies in C. elegans show that 
class II and class III PI3Ks act sequentially to promote two waves of PtdIns3P 
generation for proper phagosome maturation (Lu et al. 2012). A first wave of 
membrane PtdIns3P generation by class II PI3K may be required to initiate 
phagosome maturation through specific downstream effectors. Class III PI3K is 
required to maintain proper levels of phagosomal PtdIns3P and regulate the 
second wave of PtdIns3P generation to complete phagosome maturation. 
Phosphatase Mtm also works to regulate PtdIns3P turnover between the two 
waves. This PtdIns3P turnover may allow for recruitment of different downstream 
effectors during each wave of Ptdins3P generation to promote different stage of 
phagosome maturation. 
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 These data provide a link to further understand PI3K68D function. Future 
directions include generating PI3K68D; PI3K59F double mutants to further 
understand class II PI3K function and the relationship between the two PI3K 
classes. These mutants can also provide insight into phosphatidylinositol 
localization during late-stage oogenesis, or potential functions of these lipids in 
engulfment or corpse processing pathways in late-stage oogenesis. 
 These genes also play a role in regulating nurse cell acidification and 
chromatin fragmentation. PtdIns3P often acts as a signaling molecule and recruit 
downstream effectors to the plasma membrane. The regulation of PtdIns3P by 
class II and III PI3Ks may contribute to the temporal activation of engulfment and 
phagocytosis pathways via PtdIns3P activity. These findings potentially link PI3K 
phosphorylation and lipid composition as a platform to regulate the recruitment 
and temporal activation of engulfment and phagocytosis pathways in follicle cells 
form proper nurse cell clearance.  
 
4.3 Other kinase genes involved in developmental PCD  
 Other kinase knockdowns that also produced a strong or very strong 
persisting nuclei include Cdk9 HMS01391, Pgk HMS00030, SNF4Agamma JF02060, Stlk 
JF02796, Tefu HMS02790, Tlk HM05272, and Wnk HMJ02087. Shark was previously shown 
to be required in follicle cells for engulfment (Timmons et al. 2016) and was used 
as a positive control (Figure 4.4).   
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 Cdk9 (Cyclin-dependent kinase 9) associates with cyclinT to form a 
heterodimer (P-TEFb). P-TEFb then targets RNA polymerase II to modulate 
transcript elongation activity (Sims et al. 2004). Cdk9 HMS01391 flies also exhibited 
a very strong persisting nuclei phenotype with stretch follicle cells.  
 Pgk (phosphoglycerate kinase) is an important kinase involved in 
glycolysis. Studies in the Drosophila brain show that glycolysis is required in glial 
cells for neuronal survival (Volkenhoff et al. 2015). Inhibition of glycolysis 
specifically in the glial cells leads to a decrease in the flies’ lifespan. These flies 
also exhibit holes in their brains characteristic for neurodegeneration, and have a 
significant increase in activated caspase activity. Pgk HMS00030 flies had a very 
strong persisting nuclei phenotype. The stretch follicle cells were still present 
between the nurse cells. These ovaries also had a lot of extra tissue and nurse 
cell nuclei at the posterior end, near the oviduct.  
 SNF4Agamma is the regulatory gamma subunit for 5’-AMP-activated 
protein kinase. In Drosophila, it is involved in the FOXO pathway in low nutrient 
conditions. SNF4Agamma is also required for autophagic cell death in the larval 
fat body (Lippai et al. 2008). SNF4Agamma knockdown in follicle cells produced 
a strong persisting nuclei phenotype. The stretch follicle cells were still present. 
Interestingly, knockdown also produced an engulfment defective phenotype in 
dying mid-stage egg chambers. Mid-stage dying egg chambers had prematurely 
dying or missing follicle cells, and no follicle cell membrane. Healthy mid-stage 
egg chambers looked normal. 
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 Stlk, or Ste20-like kinase, is involved in apoptosis, the cell cycle, cell 
migration, and cytoskeleton rearrangements (Al-Zahrani et al. 2012). Stlk JF02796 
had a persisting nuclei and dumpless phenotype. Figure 4.5 shows a stage 14 
egg chamber with persisting nuclei that are surrounded by cytoplasmic material. 
These nurse cells were not able to dump their cytoplasmic contents into the 
oocyte, resulting in this dumpless phenotype. The nurse cells were still 
surrounded by stretch follicle cells. 
 Tefu, or telomere fusion, is the Drosophila homolog of ATM (ataxia 
telangiectasia mutated) checkpoint kinase. ATM is involved in regulating 
telomere capping in Drosophila. Loss of ATM leaves telomeres susceptible to 
fusion events and genomic instability (Rong 2008). Tefu HMS02790 resulted in a 
very strong persisting nuclei phenotype. The stretch follicle cells were present.  
 Tlk, or tousled-like kinase, plays an important role in chromatin assembly 
and DNA damage response. Tlk substrates include Asf1 (histone chaperone), 
histone H3-S10, Aurora B, and Rad9 (De Benedetti 2013). More recently, Tlk has 
been shown to initiate a new type of programmed cell death in the Drosophila 
eye. Ectopic expression of Tlk leads to an induction of PCD, and loss of Tlk 
function inhibits cell death (Zhang et al. 2016). In the ovary, Tlk HM05272 showed a 
strong persisting nuclei phenotype, and the stretch follicle cells were present. 
 Wnk kinase (Wnk), is a Ser/Thr kinase that signals through another 
downstream kinase, fray (Sato and Shibuya 2013). In mammals, Wnk activation 
is involved in regulating ion transport, proliferation through the MAPK signaling, 
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and cell survival (Moniz and Jordan 2010). Wnk HMJ02087 also resulted in a 
dumpless and persisting nuclei phenotype. The stretch follicle cells were present.  
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Figure 4.1 Knockdown of class II and class III PI3-kinases result in a strong 
persisting nuclei phenotype 
 
(A-C) Well-fed egg chambers were stained with DAPI to label DNA (left), and 
imaged with DIC to identify stage 14 egg chambers with fully formed dorsal 
appendages (A) Sibling control stage 14 egg chambers did not have nurse cell 
nuclei. (B) PI3K68D JF01193 egg chambers exhibited a strong PN phenotype with 
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an average of 6 persisting NC nuclei. (C) PI3K59F HMS00261 egg chambers 
exhibited a strong PN phenotype with an average of 4 persisting NC nuclei. (D) 
Quantification of persisting nuclei per stage 14 egg chambers in PI3K68D JF01193 
and PI3K59F HMS00261 egg chambers. 
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Figure 4.2 PI3K68D JF01193 and PI3K59F HMS00261 show decreased acidification in 
stage 13 egg chambers.  
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(A-C) Well-fed egg chambers were stained with DAPI to label DNA and 
LysoTracker to label acidified compartments. DIC (left panels) showed the 
beginning of dorsal appendage formation used to identify stage 13 egg 
chambers. (A-A’’) Sibling control egg chambers showed few persisting nuclei. 
Most of the nuclei were acidified (arrows). (B-B’’) PI3K68D JF01193 egg chambers 
exhibited more persisting nuclei. Very few of these nurse cells were acidified 
(arrow). (C-C’’) PI3K59F HMS00261 egg chambers exhibited few acidified NC nuclei 
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(arrow). (D) Percentage of LysoTracker positive NC nuclei in stage 13 egg 
chambers. Data presented are mean ± SEM. p-values were determined using a 
two-tailed t test and indicate significance compared to the control. ****p <0.0001 
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Figure 4.3 Quantification of other genes required for late-stage nurse cell 
elimination. 
 
Well-fed stage 14 egg chambers were scored for the number of persisting nuclei 
(PN). Number of PN were categorized into bins of 0, 1-3, 4-6, 7-9, 10-12, 13-15 
and the percentage of stage 14 egg chambers per bin was calculated. Strong 
and very strong late-stage phenotypes were graphed above.  
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Figure 4.4 Other genes required for late-stage nurse cell elimination 
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Well-fed egg chambers were stained with DAPI to label DNA and persisting 
nuclei (PN). DIC was used to visualize stage 14 egg chambers with fully formed 
dorsal appendages (not shown). (A) Shark HMS04460 had a very strong PN 
phenotype. (B) Cdk9 HMS01391 had a very strong PN phenotype. (C) Pgk HMS0003 
had a very strong PN phenotype with many extra floating nuclei. (D) 
SNFAgamma JF02060 had a strong PN phenotype. (E) Stkl JF0796 were dumpless 
and exhibited a very strong PN phenotype. (F) Tefu HMS02790 were dumpless and 
exhibited a very strong PN phenotype. (G) Tlk HM05272 had a strong PN 
phenotype. (H) Wnk HMJ02087 had a very strong PN phenotype. 
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CHAPTER FIVE Kinase genes required for nurse cell engulfment in mid-
oogenesis 
5.1 PI3K92E is required for progression during engulfment 
 PI3K92E is the Drosophila type I phosphoinositide 3-kinase. PI3K92E has 
been well-characterized in Drosophila and other organisms as part of the 
PI3K/AKT/TOR pathway. Knocking down PI3K92E in follicle cells did not produce 
a strong engulfment defect phenotype in mid or late-stage oogenesis. Instead, 
there seemed to be a partial delay in engulfment. Figure 5.1 shows the phases of 
death in a mid-stage egg chamber in PI3K92E JF02770 and sibling control flies.  
 Phase 0 egg chambers are healthy egg chambers with “fluffy” dispersed 
nurse cell chromatin surrounded by an organized layer of follicle cells. As egg 
chambers begin to die, phase 1 egg chambers are characterized by the 
beginnings of chromatin condensation. The follicle cell membrane is still thin and 
the germline has not been engulfed. PI3K92E JF02770 phase 1 egg chambers 
resembled those of sibling controls. Phase 2 egg chambers are characterized by 
nurse cell chromatin condensation with apparent individual nuclear regions, and 
the follicle cell membrane enlarges to about double its height. As egg chambers 
progress to phase 3, nurse cell chromatin becomes highly condensed into little 
balls of DNA. In wild-type egg chambers, the follicle cell membrane enlarges to 
about triple its original height, and the germline region becomes visibly small as it 
is being engulfed by follicle cells.  
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 Some of the PI3K92E JF02770 egg chambers exhibited a delay in follicle cell 
membrane enlargement during phases 2 and 3 of death. Egg chambers 
characterized as phase 2 or 3 based on chromatin morphology had follicle cell 
membranes that resembled phase 1 egg chambers. Additionally, there was no 
obvious reduction of the germline region, suggesting there is little engulfment of 
the germline material. About half of the PI3K92E JF02770 egg chambers exhibited 
this delayed membrane enlargement in phases 2-3. The rest of the phase 2 and 
3 PI3K92E JF02770 egg chambers resembled wild-type degenerating egg 
chambers. As death progressed, PI3K92E JF02770 follicle cells did eventually 
enlarge to resemble wild-type phase 4 and 5 egg chambers.  
 
5.2 PI3K92E and Pdk1 knockdowns cause excessive cell death 
 Interestingly, PI3K92E JF02770 flies also produced a mild number of mid-
stage dying egg chambers despite being well-fed. Pdk1 JF02807 flies produced a 
more excessive number of mid-stage degenerating egg chambers only when 
conditioned (Figure 5.2). Based off nuclei morphology, these egg chambers 
would be characterized as phase 3 or 4 dying egg chambers. However, these 
egg chambers contained a large amount of un-engulfed germline material, and 
the follicle cells failed to enlarge. α-cleaved Dcp-1 antibody staining showed that 
Dcp-1 caspase was activated in these dying egg chambers. Interestingly, both 
genotypes had normal numbers of degenerating egg chambers under nutrient 
deprivation and death seemed to progress normally. 
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5.3 Discussion and future directions 
 While PI3K92E is not required for engulfment in mid or late-stage 
oogenesis, the delayed engulfment phenotype exhibited here suggests that 
PI3K92E signaling could temporally affect engulfment progression. Previous 
studies have shown PI3K92E signaling to modulate Draper levels in the 
Drosophila brain (Doherty et al. 2014). In the, brain, glial cells have a phagocytic 
function via Draper in response to axonal injury. Decreased PI3K92E leads to a 
decrease in glial Draper, but does not completely deplete glial Draper levels or 
inhibit axon debris clearance. Instead, axon clearance is delayed, but ultimately 
all of the debris is cleared. Stat92E transcription factor is required to upregulate 
Draper levels to facilitate engulfment. These data suggest a model where the 
PI3K92E/AKT pathways are involved in regulating basal levels of Draper, and 
STAT92E is involved in upregulating Draper levels for engulfment. 
 This evidence suggests a link between PI3K92E, Draper, JNK, and 
engulfment in the Drosophila ovary. Previous work has shown that Draper is 
required in follicle cells for engulfment during mid-stage oogenesis and JNK 
signaling acts downstream of Draper to promote engulfment (Etchegaray et al. 
2012). PI3K92E JF02770 flies showed a delay in follicle cell engulfment similar to 
the engulfment delays in the Drosophila brain. PI3K92E may be required in 
follicle cells to regulate basal Draper levels to initiate follicle cell engulfment. 
Once Draper is activated, it may signal through JNK to promote enrichment of 
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Draper and other engulfment genes to stimulate germline clearance. Future 
experiments to answer these questions include analyzing PI3K92E JF02770 mid-
stage egg chambers for Draper expression and JNK activation.  
 The excessive degenerating phenotype from PI3K92E JF02770 and Pdk1 
JF02807under nutrient rich conditions suggests a link between the insulin signaling 
pathway and induction of cell death. Previous work has shown that insulin 
signaling and the TOR pathway are required in follicle cells to transmit nutrient 
information to the germline to mount a starvation response (Burn et al. 2015). 
Although there was an excessive number of degenerating egg chambers under 
well-fed conditions, starved PI3K92E JF02770 and Pdk1 JF0280 egg chambers had a 
normal number of dying egg chambers. If nutrient information was only 
transmitted through the insulin signaling pathway, we would expect increased cell 
death regardless of nutrient availability in PI3K92E JF02770 and Pdk1 JF0280 egg 
chambers. Thus, there may be an alternative signaling pathway that is activated 
during nutrient deprivation that signals to the germline to induce a proper 
response.  
 How insulin signaling induces cell death in the germline is still unknown. 
Insulin signaling is directly involved in cell growth and survival. But there is no 
direct link between insulin signaling and cell death. Previous work has implicated 
communication between follicle cells and the germline to mount a response to 
nutrient deprivation, however, the mechanism and signaling molecules are still 
unknown (Shimada et al. 2011; Burn et al. 2015).  
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Figure 5.1 PI3K92EJF02770 starved flies show a delayed engulfment phenotype.  
 
Starved egg chambers were stained with DAPI (blue). Cell membranes were 
stained in α-Discs Large (Dlg; red). A germline specific GFP gene trap (G89) was 
used to visualize germline material. (A-A’) Healthy wild-type phase 0 egg 
chamber with disperse NC nuclei and an organized FC layer. (B-B’) Wild-type 
phase 1 dying egg chamber characterized by NC nuclei fragmentation. The FC 
layer is still organized and the FC membrane has not enlarged. (C-C’) Wild-type 
85 
 
 
phase 3 egg chamber characterized by further NC nuclei fragmentation and 
elimination. The FC layer enlarged to about triple its original height. And there 
was an obvious reduction in germline material. (D-D’) Wild-type phase 5 egg 
chamber with little germline material left, and the FC membrane has fully 
enlarged. (E-E’)  PI3K92EJF02770 healthy phase 0 egg chambers resembled wild-
type egg chambers. (F-F’) PI3K92EJF02770 phase 1 egg chambers resembled 
wild-type phase 1 dying egg chambers. (G-G’) About PI3K92EJF02770 phase 3 egg 
chambers (characterized by nuclear chromatin morphology) had delayed 
engulfment. The FC membranes did not enlarge and there was little germline 
engulfment. (H-H’) Death proceeded normally as PI3K92EJF02770 phase 5 dying 
egg chambers resembled wild-type phase 5 egg chambers.  
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Figure 5.2. PI3K92EJF02770 and Pdk1JF02807 result in excessive mid-stage death 
despite nutrient rich conditions 
 
Conditioned egg chambers were stained with DAPI to label DNA (blue). Dying 
egg chambers are indicated by arrowheads. (A) PI3K92EJF02770 conditioned egg 
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chambers had a mild-excessive number of degenerating mid-stage egg 
chambers.  (B) Pdk1JF02807 conditioned egg chambers had a severe excessive 
number of dying egg chambers.   
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CHAPTER SIX Concluding remarks 
 Programmed cell death and cell corpse clearance is vitally important for 
an organism’s overall health and development. The genetic mechanisms behind 
engulfment by non-professional phagocytes are not well characterized. Here, we 
used the Drosophila ovary investigate the mechanisms that govern non-
professional phagocyte engulfment. Previous work has shown that the 
engulfment receptor Draper and the JNK pathway are required in follicle cells to 
promote cell death in the fly ovary. Here, we performed a kinase screen as a 
genetic approach to identify novel regulators and pathways involved in cell 
corpse clearance. This project provides a beginning point for future investigations 
for studying the mechanisms behind cell death and engulfment.  
 Overexpression of Draper is sufficient to induce germline death during 
mid-oogenesis (Etchegaray et al. 2012). Data from other members of our lab 
have identified PTEN has a candidate gene to enhance the Draper phenotype 
(Sandy Serizier and Christopher Turlo, personal communication, May 15, 2017). 
PTEN is a negative regulator of the Insulin/PI3K pathway. PTEN works to convert 
PIP3 back to PIP2 (Shim et al. 2013). In mice, knockdown of PTEN increases 
apoptotic cell corpse clearance, and overexpression of PTEN reduces 
engulfment (Mondal et al. 2011). Interestingly, this engulfment does not work 
through Akt activation. PTEN knockdown mice show an increase in Rac 
activation, F-actin polymerization, and Vav1 activation. Vav1 also contains a PH 
domain that allows it to interact with PIP3. These data suggest PTEN works as a 
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negative regulator of engulfment via PIP3 interactions.  These data, along with 
the delayed engulfment phenotype in PI3K92EJF02770 flies, point to the 
phosphorylation/dephosphorylation of phosphatidylinositol lipids as important 
regulators of engulfment.  
 Temporal enrichment of different phosphatidylinositol lipids may also play 
a role in coordinating and recruiting downstream effectors and signaling 
molecules. Studies have shown enrichment of different PtdIns during various 
stages of phagosome maturation and engulfment (reviewed in Swanson et al. 
2014). Work in C. elegans shows two waves of PtdIns3P enrichment in nascent 
phagosomes by PI3K II and PI3K III (Zou et al. 2009). These data, in conjunction 
with the strong engulfment defects from PI3K68D JF01193 and PI3K59F HMS00261 
flies, generate open questions about the temporal role of kinases and PtdIns 
enrichment to recruit binding partners, and their role in regulating cell death and 
clearance. 
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APPENDIX A 
Table A.1 Summary of all kinase genes and RNAi lines investigated 
Kinase genes were knocked down in the follicle cell using RNAi. Each line was 
analyzed for defects in nurse cell clearance in mid and late-stage oogenesis. 
Starred (*) experiments were performed by Jeffrey Taylor.  
Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Abl tyrosine kinase * JF02960 VALIUM10 N/A 
BDSC Activated Cdc42 kinase * HMS00839 VALIUM20 38.0% 
BDSC Activated Cdc42 kinase * JF02729 VALIUM10 N/A 
BDSC Activated Cdc42 kinase * HMS00892 VALIUM20 71.0% 
BDSC Activated Cdc42 kinase-like * JF03110 VALIUM10 N/A 
BDSC Activated Cdc42 kinase-like * HMS02328 VALIUM20 N/A 
BDSC aarF domain containing kinase HMS02533 VALIUM20 2.0% 
BDSC Akt1 * HM04007 VALIUM1 N/A 
BDSC alicorn * HMS00316 VALIUM20 40.0% 
BDSC Alk * JF02668 VALIUM10 N/A 
BDSC atypical protein kinase C HMS01320 VALIUM20 N/A 
BDSC atypical protein kinase C * HMS01689 VALIUM20 N/A 
BDSC atypical protein kinase C * JF01966 VALIUM10 N/A 
BDSC atypical protein kinase C * HMS01411 VALIUM20 N/A 
BDSC Arginine kinase * HMS02262 VALIUM20 100.0% 
BDSC Arginine kinase * JF02699 VALIUM10 N/A 
BDSC Autophagy-specific gene 1 * JF02273 VALIUM10 N/A 
BDSC aurora * HM04011 VALIUM1 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC aurora * HMS01511 VALIUM20 100.0% 
BDSC aurora * HMS02205 VALIUM20 6.0% 
BDSC auxillin * JF03129 VALIUM10 N/A 
BDSC abnormal wing discs * HMS00591 VALIUM20 N/A 
BDSC baboon * JF01953 VALIUM10 N/A 
BDSC ballchen * JF01308 VALIUM1 N/A 
BDSC basket * JF01275 VALIUM1 N/A 
BDSC basket * JF01274 VALIUM1 N/A 
BDSC basket * HMS00777 VALIUM20 N/A 
BDSC bent * JF01108 VALIUM1 N/A 
BDSC bent * JF01107 VALIUM1 N/A 
BDSC Btk family kinase at 29A * JF01797 VALIUM10 N/A 
BDSC breathless * HMS02038 VALIUM20 N/A 
BDSC Bub1-related kinase * GLV21065 VALIUM21 N/A 
BDSC Cadherin 96Ca * JF02579 VALIUM10 N/A 
BDSC Calcium/calmodulin-dependent protein kinase I * JF02268 
VALIUM
10 N/A 
BDSC Calcium/calmodulin-dependent protein kinase II * JF03336 
VALIUM
10 N/A 
BDSC CASK ortholog * HMS00644 VALIUM20 100.0% 
BDSC Cyclin-dependent kinase 1 * HMS01531 VALIUM20 N/A 
BDSC Cyclin-dependent kinase 1 * JF03004 VALIUM10 N/A 
BDSC Cyclin-dependent kinase 1 * HMS02212 VALIUM20 N/A 
BDSC CG7597 * HMS00155 VALIUM20 N/A 
BDSC Cyclin-dependent kinase 2 * HMS01543 VALIUM20 N/A 
BDSC Cyclin-dependent kinase 2 * HMS00174 VALIUM20 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Cyclin-dependent kinase 4 * JF02795 VALIUM10 N/A 
BDSC Cyclin-dependent kinase 5 * JF02667 VALIUM10 N/A 
BDSC Cdk5 activator-like protein * JF02374 VALIUM10 N/A 
BDSC Cyclin-dependent kinase 9 HMS01391 VALIUM20 N/A 
BDSC Cyclin-dependent kinase 9 HMS02329 VALIUM20 44.0% 
BDSC CG10082 * HMS00598 VALIUM20 N/A 
BDSC CG10082 * HMS00427 VALIUM20 N/A 
BDSC CG10177 * JF01965 VALIUM10 N/A 
BDSC CG10702 HMS02499 VALIUM20 N/A 
BDSC CG11221 JF03282 VALIUM10 N/A 
BDSC CG12069 JF02756 VALIUM10 N/A 
BDSC CG12147 HMS02447 VALIUM20 N/A 
BDSC CG17528 HMJ02234 VALIUM20 5.0% 
BDSC CG17528 JF02061 VALIUM10 N/A 
BDSC CG17698 HMS01475 VALIUM20 25.0% 
BDSC CG2246 HMS02259 VALIUM20 N/A 
BDSC CG2577 * HMS00054 VALIUM20 N/A 
BDSC CG3008 * HM04045 VALIUM20 N/A 
BDSC CG31140 HMS03006 VALIUM20 N/A 
BDSC CG31643 HMJ02237 VALIUM20 9.0% 
BDSC CG32944 * JF02591 VALIUM10 N/A 
BDSC CG34357 HM05010 VALIUM10 N/A 
Vienna CG3837 * HMS02444 VALIUM20 N/A 
BDSC CG42366 * JF02599 VALIUM10 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC CG43143 JF02162 VALIUM10 N/A 
BDSC CG4629 * JF02618 VALIUM10 N/A 
BDSC CG4839 * JF02372 VALIUM10 N/A 
BDSC CG5144 * HMS00387 VALIUM20 N/A 
BDSC CG7094 * HMS02489 VALIUM20 N/A 
BDSC CG7156 HMS01983 VALIUM20   
BDSC CG7236 * JF02655 VALIUM10 N/A 
BDSC CG7362 * HMS00449 VALIUM20 N/A 
BDSC CG8173 * JF01161 VALIUM1 N/A 
BDSC Casein kinase I alpha * HMS02276 VALIUM20 N/A 
BDSC Casein kinase I alpha * JF01792 VALIUM10 N/A 
BDSC casein kinase II alpha * JF01436 VALIUM1 N/A 
BDSC Casein kinase II beta subunit HMS00058 VALIUM20 N/A 
BDSC Casein kinase II beta subunit * JF01195 VALIUM10 N/A 
BDSC C-terminal Src kinase * HMS02277 VALIUM20 100.0% 
BDSC Cyclin H * HMS01212 VALIUM20 N/A 
BDSC Cyclin T * HMS00776 VALIUM20 N/A 
BDSC Cyclin T * HM04074 VALIUM1 N/A 
BDSC discs overgrown * JF02800 VALIUM10 N/A 
BDSC Diacyl glycerol kinase * JF03396 VALIUM10 N/A 
BDSC Diacyl glycerol kinase * HMS02341 VALIUM1 N/A 
BDSC Diacyl glycerol kinase * HMS03005 VALIUM20 N/A 
BDSC discs large 1 * JF01365 VALIUM10 N/A 
BDSC Death-associated protein kinase related JF03385 
VALIUM
10 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC derailed JF03281 VALIUM10 N/A 
BDSC Derailed 2 * JF01981 VALIUM10 N/A 
BDSC Downstream of raf1 * JF01697 VALIUM1 N/A 
BDSC Downstream of raf1 * HMS00037 VALIUM20 N/A 
BDSC Downstream of raf1 * HMS00145 VALIUM20 36.0% 
BDSC Downstream of raf1 * HMS00710 VALIUM20 N/A 
BDSC ether a go-go * JF01472 VALIUM1 N/A 
BDSC ether a go-go * JF01471 VALIUM1 N/A 
BDSC Epidermal growth factor receptor * JF01083 
VALIUM
1 N/A 
BDSC Epidermal growth factor receptor * JF02283 
VALIUM
20 N/A 
BDSC Epidermal growth factor receptor * JF02384 
VALIUM
20 N/A 
BDSC Epidermal growth factor receptor * JF01368 
VALIUM
10 N/A 
BDSC Epidermal growth factor receptor * JF01696 
VALIUM
1 N/A 
BDSC Epidermal growth factor receptor * JF01084 
VALIUM
1 N/A 
BDSC Ecdysone-induced protein 63E * HMS00569 
VALIUM
20 100.0% 
BDSC eag-like K[+] channel * JF01839 VALIUM10 N/A 
BDSC Eph receptor tyrosine kinase * HMS01986 VALIUM20 69.0% 
BDSC Extracellularly regulated kinase 7 HMS00222 
VALIUM
20 N/A 
BDSC Focal adhesion kinase * JF02484 VALIUM10 N/A 
BDSC four-jointed JF02843 VALIUM10 N/A 
BDSC four-jointed * HMS01310 VALIUM20 71.0% 
BDSC foraging JF01181 VALIUM1 N/A 
BDSC foraging * JF01449 VALIUM20 N/A 
Vienna foraging * HM04080 VALIUM1   
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Fps oncogene analog * HMS00249 VALIUM20 25.0% 
BDSC frayed HMS01794 VALIUM20 77.0% 
BDSC fused * JF01490 VALIUM1 N/A 
BDSC four wheel drive JF03329 VALIUM10 N/A 
BDSC four wheel drive * JF01701 VALIUM1 N/A 
BDSC Germinal centre kinase III * HM04054 VALIUM1 N/A 
BDSC gilgamesh * JF02903 VALIUM10 N/A 
BDSC gilgamesh * HMS01609 VALIUM20 26.0% 
BDSC G protein-coupled receptor kinase 2 * HMS00161 
VALIUM
20 N/A 
BDSC G protein-coupled receptor kinase 2 * HMS02330 
VALIUM
20 100.0% 
BDSC grapes JF02588 VALIUM10   
BDSC grapes HMS01573 VALIUM20 80.0% 
BDSC greatwall HMS00834 VALIUM20 N/A 
BDSC hemipterous * JF03137 VALIUM10 N/A 
BDSC hopscotch HMS00761 VALIUM20 N/A 
BDSC hippo * JF02740 VALIUM10 N/A 
BDSC hippo * HMS00006 VALIUM20 24.0% 
BDSC heartless HMS01437 VALIUM20 51.0% 
BDSC IplI-aurora-like kinase JF03107 VALIUM10   
BDSC IkappaB kinase-like 2 HMS01188 VALIUM20 50.0% 
BDSC inactivation no afterpotential C JF02391 VALIUM20 N/A 
BDSC inactivation no afterpotential C JF02958 VALIUM20 N/A 
BDSC Insulin-like receptor * JF01482 VALIUM1 N/A 
BDSC Insulin-like receptor * JF01183 VALIUM1 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Inositol 1,4,5-triphosphate kinase 1 HM04042 
VALIUM
1 N/A 
BDSC Inositol 1,4,5-triphosphate kinase 2 HMC02364 
VALIUM
20 N/A 
BDSC Inositol-requiring enzyme-1 * HMS03003 VALIUM20 43.0% 
BDSC JIL-1 * HMJ02230 VALIUM20 100.0% 
BDSC kinase suppressor of ras HMS00730 VALIUM20 63.0% 
BDSC licorne JF01433 VALIUM1 N/A 
BDSC LIM-kinase1 HMJ02235 VALIUM20 100.0% 
BDSC LIM-kinase1 JF02063 VALIUM 10 N/A 
BDSC Lk6 JF02993 VALIUM10 N/A 
BDSC lkb1 HMS01351 VALIUM20 32.0% 
BDSC Leucine-rich repeat kinase HMS01937 VALIUM20 N/A 
BDSC Leucine-rich repeat kinase HMS00456 VALIUM20 28.0% 
BDSC MLF1-adaptor molecule HMJ02096 VALIUM20 N/A 
BDSC MLF1-adaptor molecule JF01435 VALIUM1   
BDSC mushroom bodies tiny HMS02278 VALIUM20 93.0% 
BDSC mushroom bodies tiny JF03311 VALIUM10 N/A 
BDSC meiotic 41 * HMS02331 VALIUM20 22.0% 
BDSC Mekk1 * HM05075 VALIUM10 N/A 
BDSC MAP kinase kinase 4 * HMS02524 VALIUM20 N/A 
BDSC minibrain HMS01545 VALIUM20 3.0% 
BDSC minibrain HM05098 VALIUM10 N/A 
BDSC mos HMS02467 VALIUM20 2.0% 
BDSC Mpk2 * JF02625 VALIUM10 N/A 
BDSC Mpk2 * HMS01224 VALIUM20 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC misshapen HMJ02084 VALIUM20 5.0% 
BDSC misshapen * JF03219 VALIUM10 N/A 
BDSC Multi-substrate lipid kinase HMS00699 VALIUM20 N/A 
BDSC Numb-associated kinase HMS01793 VALIUM20 54.0% 
BDSC Nek2 HMS04457 VALIUM20 4.0% 
BDSC Nek2 HM05088 VALIUM10 N/A 
BDSC nimA-like kinase HMJ02114 VALIUM20 N/A 
BDSC nimA-like kinase HMS01477 VALIUM20 N/A 
BDSC neither inactivation nor afterpotential C JF02773 
VALIUM
10 N/A 
BDSC nemo JF01799 VALIUM10 N/A 
Vienna nemo * HMJ02229 VALIUM20   
BDSC nemo * HMJ02229 VALIUM20 69.0% 
BDSC no-on-and-no-off transient C HMS02342 VALIUM20 37.0% 
BDSC off-track JF01796 VALIUM10 N/A 
BDSC p38b * JF03341 VALIUM10 N/A 
BDSC PAK-kinase HM05156 VALIUM10 N/A 
BDSC PAK-kinase * HMS02279 VALIUM20 90.0% 
BDSC Pak3 HMS02500 VALIUM20 N/A 
BDSC PAS kinase JF03260 VALIUM10 N/A 
BDSC Pyruvate dehydrogenase kinase JF03050 
VALIUM
10 N/A 
BDSC Phosphoinositide-dependent kinase 1 JF02807 
VALIUM
10 N/A 
BDSC Phosphoinositide-dependent kinase 1 HMS01250 
VALIUM
20 100.0% 
BDSC pancreatic eIF-2alpha kinase HMJ02063 VALIUM20 15.0% 
BDSC Phosphofructokinase HMS01324 VALIUM20 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Phosphoglycerate kinase HMS00031 VALIUM20 N/A 
BDSC Phosphoglycerate kinase JF02889 VALIUM10 N/A 
BDSC Phosphoglycerate kinase HMS00030 VALIUM20 N/A 
BDSC Phosphorylase kinase gamma HMJ02065 VALIUM20 100.0% 
BDSC pole hole JF01483 VALIUM1 N/A 
BDSC pole hole JF01185 VALIUM1 N/A 
BDSC Phosphotidylinositol 3 kinase 59F HMS00261 
VALIUM
20 N/A 
BDSC Phosphotidylinositol 3 kinase 68D HMS01296 
VALIUM
20 N/A 
BDSC Phosphotidylinositol 3 kinase 68D JF01193 
VALIUM
1 N/A 
BDSC Pi3K92E JF02770 VALIUM10 N/A 
BDSC Pi3K92E HMC05152   N/A 
BDSC PTEN-induced putative kinase 1 HMS02204 
VALIUM
20 74.0% 
BDSC Pitslre HMS02389 VALIUM20 N/A 
BDSC Protein kinase at 92B * HMS00464 VALIUM20 6.0% 
BDSC cAMP-dependent protein kinase 1 HMC04936 
Valium2
0 N/A 
BDSC cAMP-dependent protein kinase 2 HMC04129 
VALIUM
20 N/A 
BDSC cAMP-dependent protein kinase 3 HMS01970 
VALIUM
20 35.0% 
BDSC cAMP-dependent protein kinase 3 JF02723 
VALIUM
10 N/A 
BDSC Protein C kinase 53E JF02641 VALIUM10 N/A 
BDSC Protein C kinase 53E HMS01195 VALIUM20 N/A 
BDSC Protein C kinase 98E JF02470 VALIUM10 N/A 
BDSC Protein kinase C delta JF02991 VALIUM10 N/A 
BDSC Protein Kinase D JF03144 VALIUM10 N/A 
BDSC cGMP-dependent protein kinase 21D JF02766 
VALIUM
10 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC Protein kinase related to protein kinase N JF02970 
VALIUM
10 N/A 
BDSC Protein kinase related to protein kinase N HMC04149 
VALIUM
20 N/A 
BDSC pelle HMS02332 VALIUM20 N/A 
BDSC pelle HMS04458 VALIUM20 2.0% 
BDSC pan gu HMJ02104 VALIUM20 1.0% 
BDSC polo HMS01591 VALIUM20 N/A 
BDSC polo * HMS00530 VALIUM20 N/A 
BDSC punt JF02664 VALIUM10 N/A 
BDSC punt HMS01944 VALIUM20 N/A 
BDSC PDGF- and VEGF-receptor related * HMS01662 
VALIUM
20 N/A 
BDSC polychaetoid HM05131 VALIUM10 N/A 
BDSC polychaetoid HMS00263 VALIUM20 N/A 
BDSC retinal degeneration A JF03371 VALIUM10 N/A 
BDSC Ret oncogene HMC04143 VALIUM20 N/A 
BDSC Ret oncogene HMC03102 VALIUM20 N/A 
BDSC rolled HMS00173 VALIUM20 16.0% 
BDSC Rho-kinase JF03225 VALIUM10   
BDSC Rho-kinase HMS01311 VALIUM20 34.0% 
BDSC RPS6-p70-protein kinase HMS04459 VALIUM20 5.0% 
BDSC Ribosomal protein S6 kinase II JF02814 VALIUM10 N/A 
BDSC saxophone JF03431 VALIUM10 N/A 
BDSC saxophone HMS04520 VALIUM20 15.0% 
BDSC stardust HMS00851 VALIUM20 N/A 
BDSC stardust HMS00953 VALIUM20 N/A 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC stardust HMS01652 VALIUM20 N/A 
BDSC sevenless HMC04136 VALIUM20 N/A 
BDSC sugar-free frosting HMS01280 VALIUM20 N/A 
BDSC shaggy * JF01255 VALIUM1 N/A 
BDSC shaggy * JF01256 VALIUM1 N/A 
BDSC SH2 ankyrin repeat kinase HMS04460 VALIUM20 15.0% 
BDSC SH2 ankyrin repeat kinase JF01794 VALIUM10 N/A 
BDSC Salt-inducible kinase 3 JF03002 VALIUM10 N/A 
BDSC Salt-inducible kinase 3 HM04380 VALIUM20 N/A 
BDSC Sphingosine kinase 1 HMS03007 VALIUM20 N/A 
BDSC skittles JF02796 VALIUM10 N/A 
BDSC Slowpoke binding protein JF02642 VALIUM10 N/A 
BDSC Slowpoke binding protein HMC04152 VALIUM20 N/A 
BDSC slipper HMS00742 VALIUM20 43.0% 
BDSC sallimus JF01098 VALIUM1 N/A 
BDSC sallimus JF01099 VALIUM1 N/A 
BDSC SNF4/AMP-activated protein kinase gamma subunit JF02060 
VALIUM
10 N/A 
BDSC SNF4/AMP-activated protein kinase gamma subunit HMS01205 
VALIUM
20 68.0% 
BDSC spaghetti-squash activator * JF02277 VALIUM10 N/A 
BDSC Src oncogene at 64B * JF03234 VALIUM10 N/A 
BDSC Ste20-like kinase JF02614 VALIUM10 N/A 
BDSC Ste20-like kinase HMS01295 VALIUM20 29.0% 
BDSC TBP-associated factor 1 HMS00416 VALIUM20 N/A 
BDSC TGF-beta activated kinase 1 * HMS00282 VALIUM20 54.0% 
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Source Full Name Trip # Vector 
PCR % 
Transcript 
Remaining 
BDSC TGF-beta activated kinase 1 * JF01384 VALIUM1 N/A 
BDSC TGF-beta activated kinase 1 * JF01492 VALIUM1 N/A 
BDSC Tak1-like 1 HM04186 VALIUM20 N/A 
BDSC Tao HMS01226 VALIUM20 N/A 
BDSC Tao * HMS02333 VALIUM20 N/A 
BDSC telomere fusion HMS02790 VALIUM20 24.0% 
BDSC thickveins HMS02185 VALIUM20 21.0% 
BDSC Tousled-like kinase HM05272 VALIUM10 N/A 
BDSC Tousled-like kinase * HMS00943 VALIUM20 N/A 
BDSC torso HMS00021 VALIUM20 24.0% 
BDSC Target of rapamycin * HMS00904 VALIUM20 N/A 
BDSC Target of rapamycin * HMS01114 VALIUM20 N/A 
BDSC tribbles HMS04999 VALIUM20 N/A 
BDSC tricornered JF02961 VALIUM10 N/A 
BDSC varicose HM05087 VALIUM10 N/A 
BDSC immune response deficient 1 HMS00908 VALIUM20 48.0% 
BDSC wishful thinking JF01969 VALIUM10 N/A 
BDSC wishful thinking HMS02298 VALIUM20 N/A 
BDSC wallenda * JF02675 VALIUM10 N/A 
BDSC CG7177 HMJ02087 VALIUM20 31.0% 
BDSC Wsck HMS02463 VALIUM20 N/A 
BDSC warts JF02741 VALIUM10 N/A 
BDSC warts HMS00026 VALIUM20 67.0% 
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Table A.2 Summary of kinase genes to be investigated 
Of the 355 Drosophila kinases, 167 genes remain to be investigated.  
6-phosphofructo-
2-kinase 
Adenosine Kinase 
Adenylate kinase 
1 
Adenylate kinase 
2 
Adenylate kinase 
3 
Adenylate kinase 
6 
Ady43A 
AMP-activated 
protein kinase α 
subunit 
Asator 
Bifunctional 
Phosphopantethei
ne 
adenylyltransferas
e - Dephospho-
CoA kinase 
black match 
Bub1 kinase 
Casein kinase II β 
subunit 
Casein kinase Iα 
Cdc2-related 
kinase 
Cdc7 kinase 
center divider 
Ceramide kinase 
CG10268 
CG10738 
CG11249 
CG11486 
CG11811 
CG12016 
CG12229 
CG1228 
CG1271 
CG1344 
CG13474 
CG13850 
CG14305 
CG15543 
CG15547 
CG17010 
CG1951 
CG2201 
CG2846 
CG2964 
CG30274 
CG31145 
CG31183 
CG3216 
CG32649 
CG3277 
CG33156 
CG33671 
CG34384 
CG3631 
CG3809 
CG4041 
CG42637 
CG4546 
CG4945 
CG5757 
CG5790 
CG5828 
CG6145 
CG6218 
CG6364 
CG6800 
CG7028 
CG7069 
CG7335 
CG7470 
CG7766 
CG8080 
CG8298 
CG8311 
CG8414 
CG8475 
CG8485 
CG8565 
CG8726 
CG8866 
CG8878 
CG9222 
CG9541 
CG9601 
CG9886 
CG9961 
CG9962 
crowded by cid 
Cyclin-dependent 
kinase 7 
Cyclin-dependent 
kinase 8 
Dak1 
Darkener of 
apricot 
deoxyribonucleosi
de kinase 
Dephospho-CoA 
kinase 
Diacyl glycerol 
kinase ε 
Discoidin domain 
receptor 
doughnut on 2 
downstream of 
receptor kinase 
drop out 
Dual-specificity 
tyrosine 
phosphorylation-
regulated kinase 2 
Dual-specificity 
tyrosine 
phosphorylation-
regulated kinase 3 
easily shocked 
fab1 kinase 
FER tyrosine 
kinase 
fumble 
G protein-coupled 
receptor kinase 1 
gasket 
Gcn2 
genghis khan 
Glutamate 
receptor binding 
protein 
Glycerol kinase 1 
Glycerol kinase 2 
Guanyl cyclase at 
32E 
Guanylyl cyclase 
at 76C 
happyhour 
Haspin 
Homeodomain 
interacting protein 
kinase 
I-kappaB kinase β 
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Integrin linked 
kinase 
Ipk1 
Ipk2 
KP78a 
KP78b 
krishah 
lethal (1) G0196 
lethal (2) k01209 
loki 
MabF7D6 
MAP kinase 
activated protein-
kinase-2 
marionette 
Menage a trois 1 
Monopolar spindle 
1 
mrityu 
Myt1 
Neurospecific 
receptor kinase 
Nipped-A 
nmdyn-D6 
nmdyn-D7 
p38c MAP kinase 
p53-related 
protein kinase 
PAPS synthetase 
par-1 
Phosphatidylinosit
ol 4-kinase III α 
Phosphatidylinosit
ol 4-phosphate 5-
kinase at 59B 
Phosphatidylinosit
ol 5-phosphate 4-
kinase 
Pi4KIIα 
Pk34A 
Pyridoxal kinase 
Pyruvate kinase 
rad50 
Raf oncogene 
RIO kinase 1 
RIO kinase 2 
Ror 
S6 Kinase Like 
Sak kinase 
Salt-inducible 
kinase 2 
Serine-arginine 
protein kinase at 
79D 
Sphingosine 
kinase 2 
SR Protein Kinase 
Src oncogene at 
42A 
Sterile20-like 
kinase 
sticky 
Stretchin-Mlck 
Suppressor of 
Stellate-like 
Tak1-like 2 
Tie-like receptor 
tyrosine kinase 
Transcription 
factor B1 
Transcription 
factor B4 
tube 
Unc-89 
Wee1 kinase 
yata 
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